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ABSTRACT 
Apoptosis is executed by caspase-mediated cleavage of various proteins. Elucidating the 
consequence of substrate cleavage provides us with insight into cell death and other 
biological processes. In this study, we applied the diagonal gel approach, a proteomic 
strategy, to identify substrates of the inflammatory caspase, caspase-1 and the cell death 
executioner caspase, caspase-3. Our results showed significant overlap between the 
substrates cleaved by both caspase-1 and - 3 . Such substrates are implicated in common 
cellular functions, including maintenance of the cytoskeleton, folding of proteins, 
translation, glycolysis, bioenergetics, signaling and trafficking. An important finding is 
that many glycolysis enzymes were targeted specifically by caspase-1. Processing of 
these glycolysis enzymes by caspase-1 was confirmed by cleaving in vitro transcribed 
and translated substrates with recombinant caspase-1. We have focused our further 
analysis on certain glycolysis enzymes. We have characterized the caspase-1 cleavage 
site in GAPDH. Point mutation of the Aspartic acid at position 189 to Alanine (D189A) 
in GAPDH blocked its cleavage by caspase-1. In vivo, in a mice model of septic shock, 
characterized by hyperactivation of caspase-1, we observed depletion of the full-length 
forms of these glycolysis enzymes in the diaphragm muscle. Further studies in caspase-1 
deficient mice will confirm whether this depletion, in caspase-1 proficient mice, was due 
to caspase-1 processing of the glycolysis enzymes. This provides a direct link between 
caspase-1 activation and inhibition of glycolysis, which might have important 
implications on loss of muscle contractility in septic shock. 
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RESUME 
L'apoptose ou la mort cellulaire programme est un phenomene medie en partie par les 
caspases capables de cliver plusieurs substrats. Elucider le role et les consequences du 
clivage de ses differents substrats nous fournira plus elements dans la comprehension de 
la mort cellulaire et autres processus biologiques. Dans cette etude, nous avons applique 
l'approche du gel diagonale, une strategie proteomic, afin d'identifier tous les substrats 
clives par la caspase inflammatoire, caspase-1, et les compares aux substrats clives par la 
caspase apoptotique, caspase-3. Nos resultats montrent dans un premier temps, qu'un 
nombre considerable de substrats est clive a la fois par caspase-1 et aussi par caspase-3, 
cela appuie leur commun dans des fonctions cellulaires, y compris l'entretien du 
cytosquelette, conformation proteique, la traduction, la glycolyse, bioenergie, la 
signalisation et le trafique cellulaire. Dans notre approche, nous avons remarque que 
plusieurs enzymes impliquees dans la glycolyse sont des substrats uniques de caspase-1. 
Le clivage de ces enzymes de glycolyse par caspase-1 a ete confirme in vitro en presence 
de la proteine recombinante caspase-1. Nous avons concentre notre analyse 
supplemental sur certaines enzymes telle que GAPDH. Nous avons pu caracterise le 
site de clivage de la GAPDH par capase-1, et en realisant une mutation cible de l'acide 
Aspartique de la position 189 en Alanine (D189A), on aboutit a un blocage du clivage par 
caspase-1. Nos resultats in vitro ont ete completes par une approche in vivo en utilisant un 
model animal de choc septique, une souris caracterise par une hyperactivation de 
caspase-1, nous avons pu observe une decroissance dans les formes longues de ces 
enzymes dans le muscle du diaphragme. L'utilisation de souris defectueuses en caspase-1 
vont nous demontrer si le clivage et la diminution dans la forme longue de ces enzymes 
est reellement le resultat d'un clivage par caspase-1. Cela fournira un lien direct 
entre 1'activation de caspase-1 et 1'inhibition de la glycolyse qui pourra avoir des 
percussions importantes sur la perte de contractilite du muscle dans le choc septique. 
iii 
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LITERATURE REVIEW: 
Apoptosis 
Apoptosis is a genetically programmed cell death. This process can be triggered by a 
variety of stimuli, including cytokines, hormones, viruses, and toxic insults (Creagh et al., 
2003). It is a fundamentally important process necessary for development and 
homeostasis of multicellular organisms. Inappropriate apoptosis causes human diseases, 
including neurodegenerative diseases, autoimmune disorders and cancer (Nicholson and 
Thornberry, 1997). Apoptosis is the major form of cell death, which is characterized by 
cell shrinkage, chromatin condensation, DNA fragmentation and membrane blebbing, all 
of which result in recognition and phagocytosis of apoptotic cells by phagocytes, thereby 
preventing an inflammatory response. This process is coordinated by a group of proteases, 
the caspases (Nicholson and Thornberry, 1997). 
Caspase family 
The name caspase (derived from cysteinyl-aspartate-specific proteinase) illustrates two 
distinguishing features of these enzymes: first, their catalysis is governed by a critical 
conserved cysteine residue; second, they specifically cleave after an Aspartate amino acid. 
To date, 14 mammalian family members have been identified. (Caspase-15 has been 
recently identified as an apoptotic caspase expressed in various mammalian species but 
not in humans (Eckhart et al., 2005)). 13 human caspases are known. A phylogenetic 
analysis classifies the family into two subfamilies: the caspase-1 subfamily (caspases-1, 
-4, -5, and -12) and the caspase-3 subfamily (caspases-2, 3, 6, 7, 8, 9, and 10). 
Caspase-14 is confined to the skin where it acts in skin differentiation. Caspase-1 
subfamily members predominantly play a role in inflammation, while caspase-3 
subfamily members are mainly involved in apoptosis (Nicholson, 1999). 
f~\ 
1 
I  I : 
t sis 
 1 o
ll  
 
1  
m r  
i  
 i  lt i  iti   t i   t ti  ll   t , t  
r   
m
ase f ily 
0'steinyl- ific 
 m
1l  1  
 
i  
t i   t t l., .     .  l ti  
analysis classifies the fa ily into t o subfa ilies: the caspase-l subfa ily (caspases-l, 
-4, -5, and -12) and the caspase-3 subfa ily (caspases-2, 3, 6, 7, 8, 9, and 10). 
aspase-14 is confined to the skin here it acts in skin differentiation. aspase-l 
s fa il  e ers re i a tl  la  a r le i  i fla ati , ile cas ase-  
s f il  rs r  i l  i l  i  t sis ( i ls , ). 
 
The general structure ofcaspases 
Caspases are synthesized as catalytically dormant proenzymes containing three domains: 
an N-terminal prodomain, a large subunit and a small subunit. They all have a conserved 
QACXG sequence in their catalytic center. In general, caspases can autocleave 
themselves or cleave other caspases. Based on their known or hypothetical roles in 
apoptosis, caspases are further divided into two functional subgroups: initiator and 
executioner caspases. Initiator caspases (caspases-1, 2, 8, 9 and 10) are responsible for 
initiating caspase-activation cascades. The initiator caspases have long prodomains 
containing caspase recruitment domains (CARDs) or death effector domains (DEDs), 
which promote caspase activation. The downstream or executioner caspases (caspases-3, 
6, 7, and as we present in this thesis caspase-1) are responsible for the actual dismantling 
of the cell during apoptosis and pyroptosis, which is a caspase-1-induced cell death 
associated with inflammation. Executioner caspases usually have short prodomains. 
Caspase activation 
The initiator caspases exist as monomers in the cytosol, and are activated by 
oligomerization in macromolecular complexes assembled by scaffolding molecules. 
Oligomerization of initiator caspases is triggered by the assembly of platforms that recruit 
caspases into close proximity. When oligomerized within macromolecular structures such 
as the DISC (death-inducing signaling complex), the apoptosome or the inflammasome, 
initiator caspases form an active site and subsequent cleavage within the inter-domain 
linker stabilizes their oligomers (Boatright et al., 2003, Green, 2003 #25; Green, 2003). 
The executioner caspases exist as inactive proform dimers. Their activation occurs 
through cleavage by the initiator caspases (Green, 2003). The activation pathways of the 
apoptotic caspases are discussed below as the extrinsic, intrinsic and granzyme B 
activation pathways (Creagh et al., 2003). The activation of the inflammatory caspases is 
reviewed in the caspase-1 section. 
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The extrinsic pathway 
This pathway is responsible for eliminating activated T cells (AICD-activation-induced 
cell death), as well as virally infected or transformed cells. The 3 molecular players that 
are engaged at the 
Extrinsic 
death-inducing signaling 
complex or DISC of the 
extrinsic pathways are: 1) 
Death receptors, 2) FADD, and 
3) the initiator caspases -
caspases-8 or -10. Death 
receptors include the TNF 
receptor 1 (TNF-R1), Fas also 
known as CD95, and the 
TRAIL receptors DR4 and 
DR5. FADD, also known as 
FAS-associated protein with a 
death domain, is a bimodular 
adaptor that contains a death 
domain DD but also a death 
effector domain DED. DDs, 
DEDs, CARDs (caspase 
recruitment domains) and pyrin 
domains PyDs belong to a 
group of structural domains 
Granzyme B 
C*spas»-7 
Figure 1 Apoptosis Pathways 
(Creagh, Conroy et al. 2003) 
known as the "death fold" domains that consist of 6 cc-helices and that mediate 
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homotypic protein-protein interactions (e.g. DD-DD, DED-DED, CARD-CARD and 
PyD-PyD). Upon binding to their ligands, death receptors oligomerize on the cell surface 
and assemble the DISC. In their cytoplasmic tails, death receptors contain a death domain 
(DD). In response to ligand binding, the death receptor DD associates with the death 
domain of FADD, which in turn recruits Caspase-8 via its death effector domain (DED). 
This results in the activation of the initiator caspases-8 and 10. The activated initiator 
caspases can then cleave and activate executioner caspases (figure 1) (Earnshaw et al., 
1999). TNFR1 binds to an additional adapter protein TRADD, which in turn binds to 
FADD. New evidence shows that the activation via TNF-R1 may happen in two steps: 
TNF-R1 associates with TRADD upon binding to its ligand, and then dissociates from 
TRADD due to TRADD undergoing some modification, possibly phosphorylation, which 
allows TRADD to recruit and activate caspase-8 within the cytosol (Micheau and 
Tschopp, 2003). 
The intrinsic pathway 
This pathway is responsible for the maintenance of normal cell number in neuronal 
development as well as apoptosis in response to environmental insults. Activation of this 
pathway is initiated by stimuli such as cytotoxic drugs, heat shock, ionizing radiation and 
other cellular stresses leading to mitochondrial outer membrane permeabilization 
(MOMP). MOMP results in cytochrome c release from the mitochondrial intermembrane 
space into the cytosol. Cytosolic cytochrome c binds to the WD40 repeat domain in 
APAF-1 (apoptosis protease-activating factor-1), which induces an ATP-mediated 
assembly of a heptamer complex and the recruitment of pro-caspase-9 via binding of the 
caspase-9 CARD to the CARD in APAF-1. This protein complex is known as the 
apoptosome. The activated caspase-9 then cleaves excutioner caspases (figure 1) (Creagh 
et al., 2003). 
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I Granzyme B-initiated caspase-activation pathway 
Granzyme B, a serine protease derived from cytotoxic T lymphocyte (CTL) and Natural 
Killer cells, shares with caspases a preference for aspartate residues in the PI position of 
its substrates. It is the only protease other than caspases known to cleave caspases 
(Nicholson, 1999). It can cleave caspases-3 and -8 as well as the caspase-8 substrate Bid 
and initiates apoptosis, building up an alternative apoptosis pathway in virally infected 
and tumor cell (figure 1) (Atkinson et al , 1998; Medema et al , 1997) 
Caspase activation networks 
During apoptosis, initiator caspases are activated to cleave executioner caspases. Caspase 
activation in the extrinsic pathway proceeds from the death receptor induced caspase-8 
cleaving of caspase-3 which cleaves caspase-6; the intrinsic pathway proceeds from the 
» cytochrome c:Apaf-l apoptosome complex by caspase-9 cleaving caspase-3 and 
caspases-6 and -7. At the same time, downstream caspases can cleave upstream caspases. 
For example, caspase-6 can cleave procaspases-8 and -10, and caspase-3 can cleave 
procaspase-9. The cleavage of upstream caspases by downstream caspases acts as a 
positive feedback mechanism to enhance apoptosis (Earnshaw et al., 1999).The protein 
Bid serves as a "cross-talking" molecule that transmits the apoptotic signal from the 
extrinsic to the intrinsic pathway. When caspase-8 is activated via the extrinsic pathway, 
i 
, it cleaves Bid into its active form, tBid (truncated Bid). tBid translocates to the 
mitochondria and activates pro-apoptotic members of the Bcl-2 family, Bax and Bak, to 
) cause mitochondrial outer membrane permeabilization (MOMP). In addition, the 
• mitochondrial proteins Smac/DIABLO and Omi/HtrA2 are released to prevent the 
I inhibition of caspases mediated by the IAPs (inhibitors of apoptosis proteins). Granzyme 
B also cleaves Bid into tBid and feeds the apoptotic signal to the intrinsic pathway 
O (Green, 2003) 
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it cleaves Bid into its active form, tBid (truncated Bid). tBid translocates to the 
mitochondria and activates pro-apoptotic members of the Bcl-2 family, Bax and Bak, to 
cause mitochondrial outer membrane permeabilization (MOMP). In addition, the 
mitochondrial proteins Smac/DIABLO and OmiIHtrA2 are released to prevent the 
inhibition of caspases mediated by the lAPs (inhibitors of apoptosis proteins). Granzyme 
B also cleaves Bid into tBid and feeds the apoptotic signal to the intrinsic pathway 
(Green, 2003) 
 
Regulation ofcaspases in apoptosis 
The activation of caspases is under the control of two protein families: 1) the pro- and 
anti-apoptotic proteins of the Bcl-2 family, and 2) the IAP (inhibitor of apoptosis protein) 
family. 
The Bcl-2 family 
The Bcl-2 family has anti- and pro-apoptotic members. During apoptosis, mitochondrial 
outer membrane permeabilization (MOMP) occurs. Anti-apoptotic members of the Bcl-2 
family (Bcl-2, Bcl-XL, Bcl-w and Mcl-1) prevent MOMP, and thus prevent cytochrome c 
release and the consequent apoptosome assembly and caspase-9 activation. On the 
contrary, the pro-apoptotic members BH123 proteins (Bax, Bak and Bok), when activated, 
oppose the actions of the anti-apoptotic members and promote MOMP. The BH123 
proteins are activated by another set of BH3-only proteins (Bim, Bid, Bad, Bmf, BNIP-3, 
Puma, Noxa) (Green, 2003) 
The IAP family 
Bcl-2 family members regulate caspases by acting upstream of the mitochondria in the 
intrinsic pathway. Downstream of the mitochondria, when procaspase-3 is cleaved by 
caspase-9, although enzymatically active at this point, caspase-3 is under a "brake" 
because it is bound by XIAP (X-chromosome-linked inhibitor of apoptosis protein), a 
member of the IAP family. Relief of inhibition of caspase-3 by XIAP is facilitated by 
competition of binding of Smac/DIABLO or Omi/Htra2 (released from mitochondria 
during MOMP) to XIAP (Du et al., 2000; Verhagen et al., 2000). 
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Caspase proteolytic properties 
Caspases are cysteine proteases. They are distinct from other cysteine proteases owing to 
their absolute requirement of an Asp in the PI position N-terminus of the scissile bond. 
Of the currently known human and mouse proteases, only Grairzyme B shares this 
specificity (Nicholson, 1999). The residue after the scissile bond (PI') is also important 
in that charged or bulky residues are poorly tolerated; Gly, Ala, Thr, Ser and Asn allow 
efficient catalysis, but Glu, Asp, Lys, Arg, Trp do not (Stennicke et al., 2000). Substrate 
specificity is determined by the residue at the P4 position. Screening of a positional 
scanning combinatorial substrate library divided caspases into three groups. Group I 
caspases (1,4, and 5) prefer bulky hydrophobic amino acids such as Tyr or Trp in the P4 
position. Group II caspases (2, 3, and 7) require a P4 Asp. Group III caspases (6, 8, 9, 
and 10) prefer branched chain aliphatic amino acids in the P4 position (Nicholson, 1999) 
(Figure 2). 
jj^^gmbf&im&£j|gijgj Mjwuwm£>wgj|| 
Group) 
Group li 
Group III 
Hydrophobic 
Asp 
Aliphatic 
Glu 
V 
Xxx Asp 
Caspases-1,4, 5, 13 
Caspases-2, 3, 7, CED-3 
Caspases-6, 8,9. 10, (Granzyme B) 
Figure 2 Caspase Substrates Specificity (Nicholson 1999) 
For natural proteins, however, the presence of a preferred cleavage site consisting of four 
specific amino acids is not sufficient. Enzyme regions distant from the catalytic site that 
participate in substrate binding (exosites) have been implicated in the recognition of 
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natural substrates. One example is derived from the crystal structure of caspase-8 bound 
to its natural inhibitor p35, which is the only caspase structure solved with a natural 
substrate bound to the caspase. p35 contains a loop that interacts with a face of caspase-8 
distant from its active site, suggesting that exosites interactions with the substrate might 
also be important (Fisher et al., 1999; Xu et al , 2001). The exosite interactions might 
explain the discrepancies in the cleavage consensuses between synthetic and natural 
substrates. 
Caspase substrates in apoptosis 
During apoptosis, caspases cleave a large number of proteins to disrupt cellular functions, 
which accounts for the phenotype seen in cells undergoing apoptosis. Caspases cleave 
key structural components of the cytoskeleton such as actin, fodrin, vimentin and keratin 
etc., which contributes to cell shrinkage and cell detachment, as well as interrupts 
antiapoptotic integrin signaling. Caspases cleave ICAD (inhibitor of caspase-activated 
Dnase). Cleavage of ICAD releases CAD liberating it to translocate to the nucleus where 
it fragments DNA. Caspases cleave numerous proteins involved in the transducation and 
amplification of apoptotic signals. For example, caspases target the survival NF-KB 
pathway, cleaving p65 and IKB-CX, TRAF-1 and RIP-1. Caspases also cleave critical 
proteins involved in the regulation of the cell cycle, such as cyclin E, MDMX, Rb, 
causing cell cycle attenuation. Additionally, caspases cleave many proteins involved in 
the translation machinery, resulting in the blockade of protein translation (Fischer et al., 
2003). 
Caspase substrates involved in neuropathologies 
The cleavage of specific substrates is directly linked to pathogenesis of certain 
neurodegenerative disorders. Huntingtin, which is mutated in Huntington's Disease and 
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possesses an expanded polyglutamine stretch in its N-terminus, is cleaved by caspase-3, 
and it is the aggregation of its N-terminal fragments in neurons which is suggested to 
cause the disease (Zhang et al., 2003b). APP, the amyloid |3 precursor protein involved in 
Alzheimer's disease, is additionally cleaved by caspase-3 at VEVD664. The consequent 
generation of the cytosolic fragment (C31) is associated with cell toxicity. Transgenic 
mice expressing an uncleavable mutant of APP (mutation of the cleavage site to alanine 
VEVD6641 A) are protected from the disease (Galvan et al., 2006). 
Synthetic inhibitors 
The sufficiency of a P4-P1 four amino acid recognition motif for caspases serves as the 
basis of inhibitor design. Reversible inhibitors of caspases are generated by coupling 
caspase-specific peptides to certain aldehyde, nitrile or ketone compounds; irreversible 
inhibitors are generated by coupling caspase-specific peptides to fluoromethyl ketone 
(FMK). To enhance cellular permeability, the inhibitors are synthesized with a 
benzyloxycarbonyl group (also known as BOC or Z), and they are widely used in both in 
vitro cell culture and in vivo studies. Examples of commercially available inhibitors are 
z-YVAD-FMK for caspase-1; z-DEVD-FMK for caspase-3; z-IETD-FMK for caspase-8 
and a pan-caspase inhibitor z-VAD-FMK (Nicholson, 1999). 
Naturally occurring protein inhibitors 
Cytokine response modifier A (CrmA) is a 38 KDa protein from cowpox virus, which 
facilitates viral infection through inhibition of cytokine production and apoptosis by 
efficient inhibition of both caspases-1 and -8 (Komiyama et al., 1994). p35 is another 
viral protein from baculovirus. Cleavage of p35 by a caspase results in the formation of a 
caspase-p35 complex. The presence of this complex prevents caspases from initiating the 
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apoptotic cascade (Xue and Horvitz, 1995). 
Non-apoptotic functions ofcaspases 
Caspases play an essential role in apoptosis. But recent studies have uncovered novel 
functions of caspases in non-apoptotic processes including the inflammatory response, 
immune cell proliferation, cell differentiation and cell migration. The major function of 
caspase-1 is in regulation of the inflammatory response by processing pro-IL-lfS, 
pro-IL-18 and pro-IL-33 into their mature cytokine forms (Li et al., 1995; Schmitz et al., 
2005). New evidence show that caspase-1 could also contribute to inflammation by the 
activation of the NF-KB pathway through the interaction between the CARD domain of 
caspase-1 and the kinase RIP1 (Lamkanfi et al., 2004). Caspase-3, the main death 
effector caspase, can process pro-IL-16 into its active form (Zhang et al., 1998), 
suggesting a role of caspase-3 in inflammation. Caspase-8 appears to play an essential 
role in T-cell proliferation and activation. It has been shown that caspase-8 cleaves the 
kinase Weel during T-cell proliferation (Alam et al., 1999), which prevents 
phosphorylation of the cell cycle-regulating kinase Cdc2 needed to promote cell cycle 
progression. Caspase-8 is also implicated in cell differentiation. Conditional knockout of 
caspase-8 in the T cell-lineage revealed a defect in T cell homeostasis and activation in 
the absence of caspase-8 (Salmena and Hakem, 2005). Additionally, conditional 
knock-out of caspase-8 in the myelomonocytic lineage resulted in an arrest in 
macrophage differentiation (Kang et al., 2004). Caspases are also involved in the 
differentiation process associated with enucleation of erythrocytes and keratinocytes 
(Zandy et al., 2005; Zermati et al., 2001). The enucleation process exhibits some 
similarities to apoptosis such as chromatin condensation and degradation of nuclear 
components (Morioka et al., 1998). Caspases are probably activated through a 
mitochondrial-dependent pathway and cleave proteins such as lamin and actin, which are 
responsible for nuclear disassembly and chromatin condensation (Zermati et al., 2001). 
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caspase-8 in the T cell-lineage revealed a defect in T cell ho eostasis and activation in 
the absence of caspase-8 (Salmena and Hakem, 2005). Additionally, conditional 
knock-out of caspase-8 in the myelomonocytic lineage resulted in an arrest in 
macrophage differentiation (Kang et al., 2004). Caspases are also involved in the 
differentiation process associated with enucleation of erythrocytes and keratinocytes 
(Zandy et al., 2005; Zermati et al., 2001). The enucleation process exhibits sorne 
si ilarities to apoptosis such as chro atin condensation and degradation of nuclear 
components ( orioka et al., 1998). Caspases are probably activated through a 
mitochondrial-dependent pathway and cleave proteins such as lamin and actin, which are 
responsible for nuclear disasse bly and chro atin condensation (Zer ati et al., 2001). 
Although caspases are activated in those cell types during enuleation, the activation level 
is not sufficient to dismantle the cell, and therefore only results in more selective 
targeting of substrates. 
Caspase-1 
Caspase-l is best known for its role in inflammation, where it cleaves pro-IL-ip and 
pro-IL18 into their active cytokine forms (Li et al., 1995). It is also implicated in cell 
death. A novel form of cell death induced by invasive bacteria, the pyroptosis, has been 
proposed and this form of cell death is dependent on caspase-1 (Fink and Cookson, 
2005). 
Caspase-1 activation, the inflammasome and the pyroptosome 
Structurally, caspase-1 has a long prodomain and is predicted to act as an initiator 
caspase. Like other initiator caspases, its activation is triggered by the assembly of a 
multimeric protein complex. This complex is known as the inflammasome, which 
resembles structurally the apoptosome. In this complex, NLR (NACHT-LRR) family 
members such as NALP1, 3, and IPAF serve as scaffolding proteins (Martinon and 
Tschopp, 2005). The activation of caspase-1 in the inflammasome is comparable to that 
of caspase-9 in the apoptosome (Figure 3). In general, NLR members are typically 
composed of three domains: a Leucine Rich Repeat (LRR) ligand sensing domain, a 
NACHT nucleotide binding and oligomerization domain, and a CARD or Pyrin domain 
(PYD) for caspase recruitment (Martinon and Tschopp, 2004; Nadiri et al., 2006). 
Four types of inflammasomes have been characterized and shown to activate caspase-1: 
NALP-1, NALP-3, NAIP5 and IPAF. (Martinon and Tschopp, 2004; Molofsky et al., 
2006). The interaction between NALP proteins and caspase-1 is not direct but depends on 
the adaptor ASC; whereas, IPAF can activate caspase-1 directly via its CARD 
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(Mariathasan et al., 2006). Recently some natural stimuli of the inflammasome have been 
identified. The NALP-3 inflammasome stimuli include bacterial RNA ((Kanneganti et a l , 
2006), uric acid crystals associated with Gout (Martinon et al., 2006), extracellular ATP, 
the toxin Nigericin and the calcium channel affecting marine toxin maitotoxin (Zamboni 
et al., 2006); the NAIP5 inflammasome is stimulated by the bacteria Legionella 
pneumophila (Fortier et al., 2006; Zamboni et al., 2006); The IPAF inflammasome is 
activated by Salmonella (Mariathasan et al., 2004) and by cytoplasmic flagellin (Miao et 
al , 2006). 
More recently, elegant work 
by Alnemri and colleagues 
have introduced a second 
caspase-1 activating complex, 
which they termed the 
"pyroptosome". The 
pyroptosome is solely 
composed of ASC dimers and 
is devoid of any NLR. It is 
hypothesized when the 
C«fl «tr&«£iN&imd$a 
Apoptosomw M Apaf-1 
Cja<spas*»S 
lUUNOEFCMWNAUM 
i n 
CMPMMMI n-
pto4L*1|k prefflL-19 
processing and smctetion 
IjInfinmmMtian • Apoploslsj 
Figure 3 Apoptosome vs. Inflammasome 
(Creagh, Conroy et al. 2003) 
activation of caspase-1 in the inflammasome is subtle, it results in controlled 
inflammation; while activation of caspase-1 by pyroptosome is more complete, which 
leads to cell death or pyroptosis. We hypothesize that pyroptosis is executed by the 
"hyperactive" caspase-1 through cleaving a wider range of cellular substrates. 
Caspase-1 function 
Caspase-1 was originally known as the interleukin-ip-converting enzyme (ICE), as it 
processes pro-IL-l|3 to its active form. Now we know that it also acts on IL-18 and IL-33. 
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The importance of caspase-1 in inflammation is highlighted by the fact that the cytokines 
that it activates have been implicated in the pathophysiology of various diseases, 
including rheumatoid arthritis, septic shock and inflammatory bowel disease (Dinarello 
and Wolff, 1993). The role of caspase-1 in inflammation is fully supported by the in vivo 
study that caspase-1 knockout mice are defective in the production of mature IL-1(3, 
IL-la and IL-18 as well as the downstream cytokines IL-6 and interferon-y, and are 
highly resistant to endotoxic shock (Kuida et al., 1995; Li et al., 1995). On the contrary, 
these mice as expected are susceptible to bacterial infections with E. coli and Salmonella 
(Joshi et al., 2002; Lara-Tejero et al., 2006). 
Caspase-1 is not involved in apoptosis due to the fact that caspase-1-deficient mice have 
no apparent defects in developmental programmed cell death and caspase-1 deficient 
cells respond normally to most apoptotic stimuli (Earnshaw et al., 1999). However, 
caspase-1 activation in macrophages infected with Salmonella or Shigella causes massive 
cell death in host (Fink and Cookson, 2006). This form of cell death is termed as 
pyroptosis as it is related to inflammation and is distinct from apoptosis, which actively 
inhibits inflammation. 
Except for caspase-1 dependent cell death in the immune system, caspase-1 function is 
also implicated in cell death in central neuron system and cardiac circulation systems. 
Mice deficent in caspase-1 are resistant to neonatal hypoxic-ischemic brain damage (Liu 
et al., 1999). Transgenic mice that express a catalytically inactive caspase-1 (C285G) 
mutant inhibit trophic factor withdrawal-induced apoptosis in dorsal root cells; similar 
results were obtained in neurons isolated from newborn caspase-1 knockout mice 
(Friedlander et al., 1997b). As well, transgenic mice with overexpresion of caspase-1 in 
heart have shown strikingly increased cardiac myocyte cell death under 
ischemia/reperfusion injury (Syed et al., 2005). This study demonstrates that 
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cardiomyocytes can respond to caspase-1 overexpression and its subsequent activation to 
initiate cell death under certain stresses. 
In contrast to pyroptosis caused by activation of caspase-1 in macrophages, a novel 
function of caspase-1 has been proposed in cell survival (Saleh, 2006). In response to a 
drop in cytosolic [k+], caspase-1 is activated via IPAF and ASC/NALP3 inflammasomes, 
followed by activation of central regulators of membrane biogenesis, the Sterol 
Regulatory Element Binding Proteins (SREBPs), which in turn promote cell survival 
(Gurcel et al., 2006). Interestingly, other caspases are also implicated in this pathway: 
SREBP1/2 were shown to be cleaved and activated by caspases (Wang et al., 1995; Wang 
et al., 1996) and Caspase-2 was found to be a transcriptional target of SREBP2 (Logette 
et al., 2005). These findings link lipid metabolism to cell death and reveal a mechanism 
by which cells regulate the balance between survival and death pathways in response to 
pathogen invasion. 
Negative regulation of caspase-1 by caspase-12 
Caspase-12 has been shown to negatively regulate caspase-1 both in humans and rodents 
(Saleh et al., 2004). A polymorphism in caspase-12 results in the production of either a 
truncated variant (caspase-12 S) or a full-length variant (caspase-12L). Most individuals 
express caspase-12S, and only about 20% of individuals of African descent express 
caspase-12L. Those individuals expressing caspase-12L have hypo-responsiveness to 
LPS-mediated production of cytokines such as IL-ip and INFy and have an increased risk 
of developing severe sepsis (Saleh et al., 2004). Like the human full-length variant of 
caspase-12, murine caspase-12 also abrogates the inflammatory response (Saleh et al., 
2006). Caspase-12 deficient mice are more resistant to sepsis and are able to clear 
bacterial pathogens more efficiently than wild-type mice. This may largely be due to the 
inhibitory effect caspase-12 has on caspase-1 (Scott and Saleh, 2007). 
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Caspase-1 substrates 
Caspase-1 is an inflammatory caspase that is responsible for maturation of 
pro-inflammatory cytokines. Although, in vitro, caspase-1 was shown to process the 
kinase PITSLRE (Beyaert et al., 1997), actin (Chen et al , 1996), parkin (Kahns et al, 
2003) and PARP (Gu et al., 1995), cleavage of these substrates occurs by other caspases 
in vivo. Pro-IL-l(3 and pro-IL-18 are the best-known caspase-1 substrates. They are 
synthesized as biologically inactive forms, which lack a leader peptide. It has been 
suggested that the precursors of IL-113 and IL-18 enter the specialized secretory lysosome 
together with components of the inflammasome, following caspase-1 activation. The 
secretory lysosome fuses with the cell membrane and the caspase-1-processed cytokines 
are released as active cytokines (Pizzirani et al., 2006). IL-33 has recently been identified 
as a caspase-1 substrate. Mature IL-33 binds to ST2 (an orphan IL-1 receptor) and results 
in the activation of NF-KB and MAPK that drive production of type 2 cytokines (e.g. 
IL-4, IL-5 and IL-13) from polarized Th2 cells. The induction of these type 2 cytokines 
by IL-33 in vivo is attributed to severe pathological changes observed in mucosal organs 
(Schmitz et al , 2005). 
We now known that caspase-1 has roles in cell death as well as in cell survival in 
addition to its well-established role in the maturation of pro-inflammatory cytokines. To 
fulfill these additional roles, caspase-1 must cleave proteins other than the precursors of 
IL-1 (3, IL-18 and IL-33. The identification of caspase-1 substrates is essential for our 
understanding of its wide range of actions. 
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GOAL OF THIS STUDY 
Cleavage of caspase substrates is central to the function of caspases. To date, more than 
280 caspase substrates have been identified. (Fischer et al., 2003). The consequence of 
substrate cleavage greatly advanced our understanding of the role of caspases in 
apoptosis. As we know, caspase-3 has a predominant role in apoptosis, but growing 
evidence indicates a non-apoptotic role of caspase-3 as well (Launay et al., 2005). The 
identification of novel caspase substrates would provide us with insights into caspase 
functions both in apoptosis and non-apoptotic processes. 
Unlike caspase-3, only few caspase-1 substrates have been identified, despite the fact that 
it was the first caspase to be cloned. These substrates include the pro-inflammatory 
cytokines pro-IL-ip and pro-IL-18, giving caspase-1 its designation as an "inflammatory 
caspase". Caspase-1, however, has been shown to induce cell death, namely macrophage 
pyroptosis in response to bacterial infection (Monack et al., 2001). Recently, the 
mechanism by which caspase-1 is activated has been characterized but the precise 
mechanism(s) by which caspase-1 initiates/executes cell death is still unclear. 
Identification of caspase-1 substrates is thus critical for completing our knowledge in this 
respect. 
The diagonal gel approach is a proteomic technique for screening for protease substrates. 
In this study, we applied this approach to identify substrates of caspases-1 and -3. 
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MATERIALS AND METHODS 
Cell culture 
THP-1 cells were cultured in RPMI 1640 (Invitrogen) supplemented with L-glutamine, 
10 % heat inactivated fetal bovine serum (FBS) and penicillin (100 U/ml) and 
streptomycin (100[Ag/ml). Cells were grown in a humidified incubator at 37° C, with 5% 
CO2 and maintained at density 1 X 106 to 1.5 X 106. Confluent Cells were split by 
diluting 1: 3 with fresh culture media. 
HEK293T and HeLa cells were cultured in DMEM (Invitrogen) supplemented with 
L-glutamine, 10 % heat inactivated fetal bovine serum supplemented with penicillin (100 
U/ml) and streptomycin (100ug/ml). Cells were grown in a humidified incubator at 37° C 
with 5% CO2. Confluent cells were split by trypsinization and by seeding 2.5 x 106 to a 
new 10 cm cell culture dish 
Human PBMC isolation and proliferation 
Human PBMCs were isolated from human blood cells by removing red blood cells using 
RBC lysis buffer (sigma). 2 x 107 cells were cultured in 15 ml RPMI. For proliferation, 
the cells were treated with 1 u.g/ml anti-CD3 antibody and 20 U/ml human recombinant 
IL-2 and cultured for 4 days in a humidified incubator at 37° C with 5% CO2. 
Diagonal gel 
THP-1 cells or human PBMCs were lysed in SDS Laemmli loading buffer (50 mM Tris 
[pH 6.8], 2% SDS, 0.1% bromophenol blue, 10% glycerol, 2.5% (3-mercaptoethanol) and 
sonicated. 400 ug of protein was resolved by SDS-PAGE 10% (first dimension). After 
migration, the lane containing the protein was excised and soaked in 40% EtOH and 10%) 
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Acetic acid for 10 min, in EtOH 30% for 10 min, and then in ultrapure water for 2 x 10 
min. The lane was then air dried until the gel started to curl and then soaked in CHEGG 
buffer (50 mM Hepes-KOH [PH 7.2], 10% glycerol, 0.1% chaps, 2 mM EDTA and 5 
mM DTT freshly added) with or without 50 jig of recombinant caspase-1 or caspase-3 
(Merck), and incubated overnight at 37°C. The lane was washed in water to remove the 
excess protease and then incubated in SDS Laemmli loading buffer for 10 min at 95°C. 
After cooling, the lane was then loaded on a second 10% SDS PAGE gel and resolved 
again. After migration, the gel was stained using Sypro Ruby (Invitrogen) or silver stain. 
Cleaved proteins, which were located under the diagonal, were excised from the gel and 
identified by mass spectrometry (at the McGill University and Genome Quebec 
Innovation Centre using LC-MS). 
In vitro cleavage assay with whole cell lysates 
Each 8 x 106 THP-1 cells were lysed in 100 ul CHEGG buffer and sonicated. Protein 
concentration was measured using Bio-Rad protein assay reagent. Each 40 ug proteins 
were incubated with 340 ng recombinant caspase-1 (Merck) or caspase-3 (Sigma) at 37 
°C for 3 hrs, then resolved on 4-12% SDS-PAGE for western blots. 
Western blot 
After SDS-PAGE, the proteins on the gels were transferred to Hybond-C Extra, 
nitrocellulose membrane (Amersham) at 50 V for 1 hr. The blots were first incubated in 
blocking buffer (Tris-buffered saline, pH 7.4 (TBS), 5% (w/v) non fat milk, 0.1 % (v/v) 
Tween 20) for 1 hr at room temperature and then incubated for 2 hrs in primary antibody 
diluted in the same buffer. After washing three times each for 10 min in 1 xTBS with 
0.1% (v/v) Tween 20 for 10 min, blots were incubated for 1 h at room temperature with 
secondary antibodies that were diluted in blocking buffer. Blots were washed three times 
in 1 x TBS, 0.2 % (v/v) Tween 20 for 5 min, and three times in 1 x TBS, 0.1% (v/v) 
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Tween 20 for 5 min. Detection was performed by chemiluminescence using ECL 
(Amersham). 
The following antibodies were used: anti- cc-enolase, aldolase, triosephosphate isomerase 
and caspase-1 P10 (Santa Cruz); anti- GAPDH (Abeam); anti- a-tubulin (sigma), anti-
IL-ip (cell signaling). 
RNA extraction andRT-PCR 
Total RNA was isolated from THP-1 cells using the Trizol Reagent (Invitrogen). Each 1 
x 106 cells were lysed in 200 ul Trizol, and extracted with 40 ul chloroform. Following 
centrifugation, RNA remained in the upper aqueous phase. The upper layer was removed 
to a fresh tube and isopropanol was added to precipitate the RNA. The RNA was 
dissolved in 50 ul DEPC water, and its concentration was measured by spectrometry. For 
first strand cDNA synthesis, 200 ng of total RNA was incubated with 1 ?g oligo (dT)i2-is 
primer (500 ?g/ml, Invitrogen), 1 ul lOmM dNTP mix in a final volume of 12 ul. The 
reaction was heated to 65 °C for 5 min and then quickly chilled on ice to allow annealing 
of the oligo (dT). The mixture was further incubated at 42 °C for 2 min in IX 
First-Strand Buffer (supplied with the kit), 0.01 M DTT and 40 U Rnase inhibitor 
(Promega). M-MLV RT (Invitrogen) was added to the mixture and incubated for 50 min 
at 37 °C, followed by enzyme inactivation at 70°C for 15 min. 
Constructs and site-directed mutagenesis 
PCR amplification of glycolysis enzymes from cDNA was carried out by mixing Taq 
DNA polymerase (Roche) 2.5 units, 1.5 mM MgCl2 0.8 mM dNTP, 5 ul template cDNA 
and 0.8 uM forward and reverse primers specific for glycolysis enzymes (table 2) in a 
final volume of 50 ul. PCR cycling was 2 min at 94 °C for initial denaturing, followed by 
10 cycles of 94 °C for 30 s, 60 °C for 60 s, and 72 °C for 60 s and 20 cycles of 94 °C for 
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30 s, 60 °C for 60 s, and 72 °C for 60 s with a elongation of 20 s for each cycle and then 
elongation at 72 °C for 7 min. The PCRs were cloned to pcDNA3.1+ (neo) vector. The 
constructs from each clone were confirmed by sequencing. 
Potential cleavage site mutations were introduced by site-directed mutagenesis using the 
QuickChange site-directed mutagenesis kit (Stratagene) following the manufacturer's 
instructions. The primers for mutagenesis were summarized in table 3. All mutations 
were confirmed by sequencing. 
In vitro cleavage of S methionine-labeled substrates 
i f 
S Methionine-labeled substrates were obtained by coupled in vitro transcription and 
translation using the Promega TNT reticulocyte lysate system. 0.7 ug of the cDNA 
constructs were incubated with T7 polymerase, rabbit reticulocyte lysates, amino acid 
mixture minus methionine, and 35S methionine for 1.5 h at 30 °C. Cleavage of the in vitro 
transcribed and translated 35S labeled products were performed by incubation at 37 °C for 
4 hrs in the presence or absence of purified human recombinant caspase-1 (Merck) in 
CHEGG buffer. The cleavage reaction was terminated by the addition of SDS Laemmli 
loading buffer and resolved by SDS-PAGE, and viewed by autoradiography. 
Caspase-1 activation with ATP/nigericin treatment 
THP-1 cells were pre-treated with 20 ng PMA for 24 hrs, and then were treated with 100 
ug LPS for overnight, followed by 20 min incubation with 5mM ATP or 20 ^M nigericin 
and then the culture media were replaced with fresh media. The cells were cultured for an 
additional 3 hrs for IL-1(3 secretion. Cells were lysed in Laemmli loading buffer and 
resolved in 4-12 % SDS PAGE for Western blot. 
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THP-1 cells Salmonella infection 
Bacterial preparation for infection 
Wild-type bacteria Salmonella (SL1344) were cultured aerobically at 37°C in 
Luria-Bertani (LB) broth or on LB agar without antibiotics. Bacteria were freshly plated 
on LB agar. To obtain stationary-phase bacteria for infection of THP-1 cells, LB broth 
was inoculated with a single colony and grown overnight with vigorous shaking. Before 
infection, bacteria were diluted 1:10 in LB broth, grew until OD600 0.9 (equivalent to 105 
bacteria/ml), and then bacteria were harvested by centrifugation, washed with PBS, and 
incubated for 20 min at 37°C in THP-1 culture media (without antibiotics). The bacteria 
were used immediately for infection of THP-1 cells. 
Cell culture and infection. 
THP-1 cells were maintained at a density of 1 x 105 to 2 x 106 cells/ml. One day prior to 
infection, the cells were harvested, washed, and resuspended in fresh medium without 
antibiotics. The cells were incubated with PMA (20 ng/ml) for one overnight to 
differentiate the cells into adherent macrophage-like cells, The next day, medium and 
nonadherent cells were removed and replaced with fresh complete medium without 
antibiotics. The cells were then primed with 50 ng/ml crude LPS for one overnight. The 
next day, the cells were infected with prepared bacteria Salmonella at a multiplicity of 
infection (moi) of 10:1 bacteria: THP-1 cells. Culture plates were centrifuged at 500 x g 
for 10 min and incubated at 37°C for 30 min to allow phagocytosis to occur. Under these 
conditions, essentially all cells are infected with bacteria. The medium was then replaced 
with fresh medium without antibiotics and incubated for additional 16 hrs. Two parallel 
wells were prepared for FLICAcasp_1 analysis and western blot for each condition. The 
cells for western blot were lysed in SDS Laemmli loading buffer and resolved on 4-12 % 
SDS PAGE. 
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FLICAcasp~ activity measurement 
FLICAcasp"1 (immunochemistry Technologies) was added to cell culture at the indicated 
time points, followed by 1 hr incubation at 37 °C. Cells were collected and washed two 
times with wash buffer (supplied with the kit) and then re-suspended in the same buffer. 
Fluorescence was measured by FACS (BD FACS Calibur) under the FL1 channel. 
Results were analyzed using the software FlowJo. 
LDH measurement ofTHP-1 cells infected with Salmonella 
THP-1 cells were aliquoted into 10 cm plates at a density of 2 X 106 cells per plate. The 
cells were treated with PMA (20 ng/ml) for one overnight. After PMA treatment, the 
media were replaced with fresh media. The cells were infected with Salmonella (moi 
1:100) following the Salmonella infection procedure. After 4 hrs of infection, the culture 
media were collected for LDH measurement using a kit from Trinity Biotech following 
its instruction. For YVAD-FMK treatment, the cells were pre-treated with YVAD-FMK 
(100 \\M) 30 min before PMA treatment, and YVAD-FMK was kept in the culture media 
at all time. 
Mice model of LPS-induced septic shock 
C57BL/6 mice (8-12 weeks old) were injected intraperitoneally with 20mg/kg LPS from 
Escherichia coli (sterotype 055:B5, Sigma). Control mice were injected intraperitoneally 
with saline. The mice were killed 12 or 24 hrs post-injection. Diaphragm muscle was 
excised and proteins were extracted for western blot. 
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RESULTS AND DISCUSION 
/. Caspases-1 and-3 substrates identified by the diagonal gel approach 
The diagonal gel approach is a technique for protease substrate screening. It was recently 
applied to identify the mitochondrial caspase-3 substrate NDUFS (Ricci et al., 2004). 
Figure 4 schematically outlines this method. In general, whole cell lysates are separated 
on a 1st dimension SDS PAGE gel. The gel lane is cut, dehydrated and then rehydrated in 
a buffer containing the protease of interest. These steps wash out the SDS and allow the 
protease to diffuse through the gel pores and digest its specific substrates. Following this 
in-gel digestion, the gel lane is loaded horizontally on a second SDS-PAGE gel and the 
proteins are resolved. Most of the proteins would migrate on a diagonal line, however 
proteins that got digested by the protease would drop under the diagonal. To validate this 
method, we subjected 400 \ig of proteins from whole cell lysates to the diagonal gel in 
the presence or absence of caspase-3. In the absence of caspase-3, all the proteins 
migrated along the diagonal line. In the presence of caspase-3, its substrates were cleaved 
and dropped below the diagonal (figure 5). Proteins were detected by staining of the 
diagonal gel with Syproruby (Invitrogen) or by silver staining. We further validated this 
technique by western blot. We loaded whole cell extracts from LPS pre-treated THP-1 
cells on a 1st dimension gel and incubated the gel with caspase-1. The cleavage of the 
known caspase-1 substrate IL-(3 was monitored by western analysis (figure 6). As shown 
in figure 6, the 34 KDa pro-IL-ip was cleaved into the mature 17 KDa IL-ip by 
caspase-1 and dropped under the diagonal. 
We chose to work with human peripheral blood mononuclear cells (PBMCs) or with the 
human monocytic cell-line THP-1 to screen for caspase-3, and caspase-1 substrates, 
respectively. 400 fxg whole cell extracts were resolved on a 1st dimension SDS PAGE, 
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the gel lanes were incubated in the presence or absence of 50ug recombinant caspase, and 
then resolved again on a 2nd dimension SDS PAGE (figure 7). The proteins that dropped 
under the diagonal were identified by mass spectrometry (at the McGill University and 
Genome Quebec Innovation Centre using LC-MS). Using this approach, we identified 85 
and 58 substrates for caspase-1 and - 3 , respectively (table 1). The criterion that we used 
to identify a peptide from PMF (peptide mass fingerprint) is an ion score for each 
peptide > 40, (which is a measure of the identity of the peptide obtained) and a peptide 
coverage larger than 10% of the size of the caspase-1 cleavage product which was 
extracted from under the diagonal. The identified substrates were classified into 
subgroups related to their cellular function: cytoskeletal proteins, chaperons, nuclear 
proteins, translation machinery proteins, immune proteins, glycolysis and bioenergetics 
proteins, and proteins involved in signaling and trafficking (figure 8). Among the 
identified substrates, 19 proteins were found to be known substrates of caspase-3 (Fischer 
et al., 2003), for example, cytoskeletal proteins: actin, filamin, gelsolin, keratin and 
vimentin; chaperons: Hsp70 and 90; proteins for RNA synthesis: hnRNP Al/A2/Cb; 
translation machinery proteins: EEFA1, Nascent polypeptide-associated complex, etc. 
(Fischer et al., 2003), which further confirmed accuracy and efficiency of this approach. 
Interestingly, caspase-1 and -3 shared 25 common substrates, which accounted for 
approximately 26% of total caspase-1 substrates and 38% of total caspase-3 substrates 
identified by this method (figure 9A). The overlapping substrates were mostly 
cytoskeletal proteins, accounting for 50% of the substrates in this subgroup (figure 9B). 
Among the 5 common cytoskeletal substrates, 4 are known caspase-3 substrates cleaved 
during apoptosis. The significant overlap of the substrates suggests that caspase-1, like 
caspase-3, may execute cell death. In our substrate list, immune proteins were unique for 
caspase-3. This may be due to the fact that we used PBMCs as a source of proteins in our 
caspase-3 substrate screen. This suggested that caspase-3 cleaves common proteins as 
well as cell-specific proteins, to fulfill its functions in apoptotic and non-apoptotic 
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processes. It is also worth noting that caspase-1 cleaved more proteins related to protein 
translation, such as translation elongation factors and ribosomal proteins, than caspase-3 
did, which implies that caspase-1 could have a dominant role in destroying the translation 
machinery during cell death. 
Although only few caspase-1 substrates are recorded in the literature, we identified a 
large number of caspase-1 substrates in our screen. It was not surprising since we know 
that the mature caspase-1 is a very active enzyme that cleaves pro-IL-l(3 very efficiently. 
Moreover, caspase-1 is very similar to caspase-3 structurally and its active site also 
recognizes the caspase-3 target motif, DEVD, with a binding affinity Kj = 17nM 
(Nicholson and Thornberry, 1997). That might explain many common substrates obtained 
for these two caspases. We validated eight substrates from our caspase-1 substrate list 
using in vitro cleavage assay either by western blot of whole cell lysates or by in vitro 
transcribed and translated S labeled substrates, two of them were not cleaved, six of 
them were shown to be cleaved by caspase-1, which means that the chance of getting true 
substrates from our list is 75%. 
More recently, stimuli such as bacterial and viral components as well as some toxins have 
been reported to activate caspase-1 via inflammasomes (Ogura et al., 2006). Our list of 
caspase-1 substrates provides cues for catching in vivo cleavage of caspase-1 substrates 
under those physiological conditions. 
2. Caspase-1 targets in the glycolytic pathway 
Glycolysis is the anaerobic catabolism of glucose, in which one molecule of glucose is 
catabolized into two molecules of pyruvate and two ATP molecules. Under aerobic 
condition, pyruvate is further oxidized by mitochondrial enzymes to CO2 and H2O 
resulting in a higher yield of ATP. In the absence of oxygen, pyruvate is converted into 
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lactate to regenerate NAD+ from NADH. Surprisingly, of all 11 enzymes involved in this 
process, 6 were found to be targeted by caspase-1 in our diagonal gel experiment (figure 
10). In addition, other enzymes related to glucose metabolism were also found in our 
caspase-1 list including: aldose reductase, which is responsible for the conversion of 
glucose to sorbitol, cAMP-dependent pyruvate kinase regulatory subunit alpha 2 for 
glycogenolysis; fructose-1,6-bisphosphatase for gluconeogenesis; transaldolase and 
N-acetylglucosamine kinase of the pentose pathway. 
As a major energy source, glucose metabolism is essential for cellular functions. Severe 
restrictions in glycolysis causes cell death, even in the presence of growth factors (Chi et 
al., 2000). Importantly, death as a result of glucose limitation proceeds via apoptosis 
(Vander Heiden et al., 2001). Cellular glucose metabolism is regulated by growth factors 
(Summers and Birnbaum, 1997). Cellular transformation occurs when cell survival, 
proliferation and metabolism become growth factor independent (Hanahan and Weinberg, 
2000). Cancer cells develop strategies to shift their metabolism to glycolysis even in the 
presence of normal oxygen pressure (Gatenby and Gillies, 2004). This phenomenon is 
termed the Warburg effect (Warburg, 1930). The accelerated glycolysis confers cancer 
cells with a selective advantage as it ensures ATP levels compatible with demands of fast 
proliferation in hypoxic micro-environmental conditions. Changes in cellular metabolism 
are sufficient to commit a cell to death or to more proliferation. Based on studies 
demonstrating that glucose metabolism is implicated in cell death and survival, we have 
reason to speculate that these two crucial processes, glycolysis and apoptosis, are linked. 
Although caspase-1 is considered as an inflammatory caspase as its major function is the 
maturation of IL-1J3 and IL-18 (Li et al., 1995), its role in cell death was also 
demonstrated in certain types of cell, such as in macrophages (Fink and Cookson, 2005), 
fibroblasts (Miura et al., 1993), neurons (Arai et al., 2006) and mammary epithelial cells 
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(Boudreau et al., 1995). But the exact mechanism by which caspase-1 functions in cell 
death is unclear. Since many glycolysis enzymes are targeted by caspase-1, investigation 
of the cellular relevance of the cleavage of these substrates will help us to disclose how 
caspase-1 executes cell death. 
2.1 validation of the cleavage of the glycolysis enzymes by caspase-1 
2.1.1 Validation of the caspase-1 cleaving glycolysis in vitro by western 
blot 
To validate the cleavage of the glycolysis enzymes by caspase-1, we performed in vitro 
cleavage assays. In these experiments, THP-1 lysates were incubated with or without 
recombinant caspase-1 then resolved by SDS PAGE on a 4-12% gel. The cleavage of 
substrates was assessed by western blot using antibodies against aldolase, a-enolase, TIM, 
GAPDH and IL-1(3. The cleavage assay of pyruvate kinase was not done due to lack of 
an antibody. Cleavage of pro-IL-ip was chosen as a positive control. Aldolase migrated 
as a doublet with one band running slightly faster than the full-length protein (figure 11). 
Cleavage of a-enolase is obvious. The cleavage products are 37 KDa, 30 KDa and 20-25 
KDa, suggesting more than one cleavage site may exist. Therefore the cleavage of 
aldolase and a-enolase was confirmed by western blot, but that of TIM and GAPDH was 
not detected by antibodies (figure 11). 
Since caspase-1 and -3 share many common substrates, we further tested the cleavage of 
a-enolase and aldolase with recombinant caspase-3. We incubated THP-1 lystates with 
excessive amounts of recombinant caspase-3 (290 ng), but no cleavage was observed in 
our western blot with antibodies against a-enolase and aldolase (figure 12). The activity 
of the caspase-3 enzyme used (Sigma) was further tested with the selective caspase-3 
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fluorogenic peptide Ac-DEVD-AMC. Caspase-3 cleaved Ac-DEVD-AMC efficiently 
with a rate of cleavage of 3.94 x 106 AFU (arbitrary fluorescent units), min"1. mg"1. We 
concluded that caspase-1 cleaves a-enolase and aldolase, but caspase-3 does not. 
2.1.2 Caspase-1 cleavage of in vitro transcribed and translated glycolysis 
enzymes 
To confirm that the glycolysis Enzymes were cleaved by caspase-1 directly, we 
performed a second cleavage assay with 35S-methionine labeled in vitro transcribed and 
translated (ITT) substrates. 
To obtain the plasmids for in vitro transcription and translation, we first extracted mRNA 
from THP-1 lysates, and cDNA of THP-1 was generated by reverse transcription, 
a-enolase, aldolase, TIM and pyruvate kinase cDNA were cloned into pCDNA3.1, a T7 
promoter containing vector. The GAPDH plasmid was purchased from ATCC and 
re-cloned into pCDNA 3.1 vector for ITT. The primers designed for PCR are listed in 
table 2. All plasmids used for ITT were confirmed by sequencing. Glycolysis enzyme 
ITT products were produced using [35S] methionine and the TNT T7 coupled rabbit 
reticulocyte lysate kit from Promega. 
S labeled ITT glycolysis enzymes were incubated with or without recombinant 
caspase-1 and -3 and then resolved by SDS PAGE. PARP, a substrate for both caspase-1 
and -3 (Gu et al., 1995), was in vitro transcribed and translated and served as a positive 
control. ITT products of a-enolase, aldolase, GAPDH, and TIM were cleaved by 
caspase-1, but not by caspase-3; whileas pyruvate kinase was cleaved by both caspase-1 
and -3 (figure 13). Caspase-1 strongly cleaved GAPDH, pyruvate kinase and a-enolase, 
but aldolase cleavage was minor in this assay. To determine the cleavage efficiency, we 
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digested ITT glycolysis enzymes with increased amount of recombinant caspase-1 from 
10 ng to 700 ng. The cleavage of GAPDH started to be seen with 10 ng of Caspase-1, but 
at least 20 ng of caspase-1 was needed for the cleavage of a-enolase (figure 14). The 
cleavage efficiency of GAPDH and a-enolase is in the same range as that of PARP, 
which also needs a minimal 25 ng of caspase-1 for its cleavage in vitro (Gu et al., 1995). 
However, the amount of caspase-1 needed for pro-IL-ip processing is 0.1 ng (figure 14). 
So, caspase-1 cleaves pro-IL-ip much more efficiently. The PITSLRE kinase, a protein 
related to the master mitotic protein kinase Cdc2, is another substrate for caspase-1. 
Similar to pro-IL-l|3, it only requires 0.25 ng of caspase-1 for its cleavage in vitro 
(Beyaert et al., 1997). Caspase-3, but not other caspases, also cleaves the PITSLRE 
kinase at the same site used by caspase-1. However, caspase-3 cleaves the PITSLRE 
kinase much less efficiently in that a minimum of 25 ng enzyme is required for the 
cleavage of its ITT product (Beyaert et al., 1997). In vivo, a study with embryonic 
fibroblasts from caspase-l"7" mice showed that the PITSLRE kinase was still cleaved to 
the same extent in the caspase-1 deficient fibroblasts as compared to wild type cells, in 
TNF-a induced apoptosis (Beyaert et al., 1997). Caspase-3 was presumably responsible 
for the cleavage of the PITSLRE kinase in the caspase-1 deficient fibroblasts although it 
cleaved this substrate less efficiently than caspase-1 in vitro. This demonstrates that 
enzymes with lower efficiency in vitro could also have effects in vivo. 
An interesting phenomenon was observed with enolase: in vitro transcription and 
translation of full-length a-enolase resulted in the production of two polypeptides with 
molecular weights of 48 kDa and 37 kDa, respectively (figure 14 A). The 48 KDa protein 
is the expected size of full-length a-enolase. Further investigation disclosed that the 37 
KDa protein is an alternative in-frame internal AUG translated isoform (Feo et al, 2000). 
The 37 KDa alternative translation product was proposed to be MBP-1, the Myc 
promoter-binding protein-1 that serves as a repressor of c-myc transcription (Ray and 
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Miller, 1991). The evidence to support this is: First, the MBP-1 cDNA shares 97% 
similarity with the cDNA encoding a-enolase, both in the coding region and in the 
3'-untranslated sequence (Giallongo et al , 1986). Second, the chromosomal location of 
MBP-1 on human chromosome lp36, is in close proximity to that of the gene encoding 
a-enolase (Onyango et al., 1998). Third, the 37 kDa alternatively translated isoform is 
preferentially localized in the nucleus, sharing with MBP-1 the capability to 
downregulate the transcription of c-myc (Feo et al., 2000). The antibody against 
a-enolase detected both the 48 KDa and 37 KDa proteins in many cell lines (Feo et al., 
2000), but the antibody that we used (from Santa Cruz) only detected the 48 KDa form in 
THP-1 cell lysate (figure 11), whereas a 37 KDa cleavage fragment was detected in the 
lane digested with caspase-1 by western blot (figure 11). Comparison of a-enolase's 
western blot and ITT gel revealed that the cleavage product of around 20-25 KDa 
fragment was detected by both methods. The 37 KDa cleavage fragment, which was 
observed by western blot, could also exist on the ITT gel, however it would be masked by 
the 37 KDa alternative translation product (figure 14 A). It should be noted that caspase-1 
cleaved both forms of a-enolase, the 48 KDa and 37 KDa proteins. Further work needs to 
be done to examine whether caspase-1 cleaves a-enolase to generate a 37 KDa fragment. 
This could be accomplished by blocking the internal translation of the 37 KDa isoform. 
Since internal translation of the 37 KDa isoform starts at Met97 in the a-enolase cDNA 
(Feo et al., 2000), point mutation of this site could possibly block internal translation. If 
caspase-1 cleaved a-enolase into a 37 KDa fragment, it would be interesting to examine 
whether this cleavage product would have similar function as MBP-1. 
ITT of aldolase also showed a minor alternative translation form of around 22 KDa 
(figure 14 B), but this alternative translation form is not recorded in the literature. 
Caspase-1 cleaves both translation products, and the cleavage fragments migrate at 
around 28 KDa and 10 -15 KDa. 
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2.2 Identification of the caspase-1 cleavage site in the glycolysis Enzymes 
After we have confirmed that the glycolysis enzymes were directly cleaved by caspase-1, 
we then sought to map the caspase-1 cleavage sites. As caspases have a near absolute 
preference for Asp residues in the PI position, we scanned the amino acid sequence in 
cc-enolase and GAPDH for possible caspase cleavage motifs, which would generate the 
fragments shown in the ITT cleavage experiments (Figure 14). We used site-directed 
mutagenesis to change the possible Aspartate residues to Alanine in four possible 
positions in GAPDH and a-enolase (figure 15A, 16A). As shown in figure 15C, GAPDH 
mutant D189A was resistant to caspase-1 cleavage, whereas all four mutations in 
a-enolase couldn't block its cleavage by caspase-1 (figure 16 B). Inspection of the 
cleavage site of GAPDH from several species revealed that the cleavage site from PI -
P4 and PI ' (KTVD189 I G) are completely conserved among these species (figure 15 B). 
We have therefore mapped D189 as a single caspase-1 cleavage site in GAPDH. 
2.3 In vivo studies on the cleavage of the glycolysis enzymes upon 
activation of Caspase-1 
After we have identified that those glycolysis enzymes were caspase-1 substrates in vitro, 
we then tested if these substrates were cleaved in vivo in response to caspase-1 activation. 
2.3.1 Activation of caspase-1 by transfection of procaspase-1 into HEK293 
cells 
Several studies have shown that caspase-1 cleaves its substrates when over-expressed 
into HEK293 (Kahns et al., 2003; Lamkanfi et al., 2004; Zhang et al , 2003a). Since the 
glycolysis enzymes are constitutively expressed in HEK293, we transfected procaspase-1 
into HEK293, but auto-processing of caspase-1 was not observed by western blot, and 
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a-enolase and aldolase were not cleaved (data not shown). 
2.3.2 Activation ofcaspase-1 in THP-1 cells treated with LPS plus ATP or 
Nigericin 
Caspase-1 is constitutively expressed in monocytes and macrophages (Lin et al., 2000). 
Previous research has shown that activation of caspase-1 in macrophages occurs in 
response to Toll-like receptor activation and ATP treatment, the latter activating the 
P2X7 receptor which decreases intracellular K+ levels by forming a pore in the plasma 
membrane (Perregaux and Gabel, 1994; Surprenant et al., 1996). The toxin nigericin, a 
potassium ionophore was also found to activate caspase-1 and leads to the release of 
IL-ip by macrophages (Perregaux and Gabel, 1994). This process is dependent on 
caspase-1 activation within the NALP3 inflammasome (Mariathasan et al., 2006). We 
have applied this activation model to THP-1 cells. In our experiments, we pre-treated 
THP-1 cells with PMA to differentiate the cells into macrophages, and then treated with 
LPS and ATP or Nigericin. Processing of Pro-IL-ip into the 17 KDa form was shown on 
western blot (figure 17). Activated caspase-1 (plO) was not detected in western blot. The 
possible reason is that the antibody used in these experiments was raised against mouse 
caspase-1 and is not sensitive to human caspase-1. But the cleavage of a-enolase and 
aldolase was not seen by western blot. One possibility is that the activation ofcaspase-1 
was not robust enough to cleave these substrates. 
2.3.3 Activation ofcaspase-1 in Salmonella infected THP-1 cells 
The Gram-negative bacteria Salmonella was reported to infect macrophages and induce 
cell death in the host cells by activating caspase-1 (Hersh et al., 1999). Cell death of host 
cells can be advantageous or detrimental to pathogenesis. In the case of Salmonella, the 
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bacteria induces cell death as a virulence strategy for its systematic spreading into the 
host (Monack et al., 2000). The mechanism of caspase-1 activation involves the assembly 
of an IPAF inflammasome (Mariathasan et al., 2006), and the consequent activation of 
the ASC pyroptosome (Alnemri, 2007). Salmonella infection-induced pyroptosis has 
been characterized as a caspase-1 dependent cell death as it is distinct from classical 
apoptosis and caspase-3 is not involved in this process (Monack et al., 2001). Therefore it 
was very important to investigate caspase-1 substrates cleavage during this process. We 
infected THP-1 cells with Salmonella. We first treated THP-1 cells with PMA to 
differentiate the cells into macrophages, primed the cells with a low dose of LPS, and 
then infected with Salmonella at different multiplicity of infection (moi). 24 hours 
post-infection, massive macrophage cell death was observed in culture. In this 
experiment, activation of caspse-1 was monitored using the fluorescent reagent 
FLICAcaspl, which binds to the active form of caspase-1 with high affinity. Our results 
showed that PMA treatment induced around 10% caspase-1 activation detected by 
FLICAeaspl (figure 18), however, no pro-IL-ip processing or caspase-1 auto-cleavage 
were observed in response to PMA. In response to LPS treatment, caspase-1 activation 
increased to 31%, but pro-IL-l|3 and caspase-1 were not yet processed. Salmonella 
infection activated caspase-1 up to nearly 100% and pro-IL-ip was processed into IL-1(3. 
Protein level of caspase-1 is low in western blot, which is consistent with previous 
research showing that caspase-1 is secreted with IL-ip from the macrophage upon 
activation (Andrei et al., 2004). Surprisingly, cc-enolase and aldolase were completely 
degraded (The bands detected by western blot were due to cross reactivity of the 
antibodies with bacterial enolase, which migrated slightly faster than mammalian 
a-enolase derived from THP-1). This suggests that they might be degraded in the cell 
after a 24 hr-infection with Salmonella. It has been reported that caspase substrates 
DIAP1 (an Drosophila inhibitor of apoptosis) and TWIST (a transcription factor essential 
for mesodermal development) are degraded by ubiquitin/proteosome pathways after 
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caspase cleavage (Demontis et al., 2006; Ditzel et al., 2003). In the case of DIAP1, when 
it is cleaved by a caspase, the N-end Asn is exposed, which sensitizes the protein to be 
degraded by the ubiquitin dependent N-end rule pathway (Ditzel et al., 2003). Similarly, 
caspase cleaves off the C-terminus of TWIST, which greatly affects stability of the 
protein and thus triggers its degradation by the lysine dependent ubiquitination pathway 
(Demontis et al., 2006). Based on the depletion of the glycolysis enzymes after 
Salmonella infection in THP-1 cells and on the results showing that the glycolysis 
enzymes were cleaved by caspase-1 in vitro, we hypothesize that the caspase-1 cleavage 
might target the glycolysis enzymes to ubiquitin-dependent degradation. 
2.3.4 Examination of the glycolysis enzymes cleavage in the mice muscle 
in Septic shock 
Septic shock is characterized by a systemic inflammatory response to an infection or 
injury, in which a group of inflammatory cytokines, such as TNFcc, IL-ip, IL-6, IL-8 and 
IL-18 are released by inflammatory cells (Cavaillon et al., 2003; Endo et al., 2000; 
Grobmyer et al., 2000). Excessive activation of caspase-1 has been reported in this 
condition (Oberholzer et al., 2000). As we know, glucose metabolism is linked to muscle 
function in that ATP provides energy for muscle contraction. Therefore, Glucose 
metabolism, as the major source of energy in the skeletal muscle, is essential for muscle 
function. Patients in septic shock develop muscle weakness caused by loss of 
contractile ability of their skeletal muscles (Ginz et al., 2005). Posttranslational 
modifications of glycolysis enzymes have been observed in the diaphragm of septic 
rodents (Barreiro et al., 2005; Hussain et al., 2006). LPS injection in rats has been shown 
to cause muscle wasting: The isometric force generated by the diaphragm significantly 
and progressively declined in this septic shock model (Barreiro et al., 2005). We 
examined the cleavage of the glycolysis enzymes in the diaphragm of mice subjected to 
the septic shock model. For this part of the work, we collaborated with Dr. Sabah 
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Hussain's lab. Mice were injected intraperitoneally with LPS and killed 12 hrs or 24 hrs 
after injection. The diaphragms were excised to extract protein. 50 ug of total proteins 
were subjected SDS PAGE and probed with antibodies against a-enolase, adolase, 
GAPDH, TIM and actin. Actin was chosen as a loading control. Our results show that 
proforms of all the glycolysis enzymes examined were greatly decreased 24 hrs post LPS 
injection (figure 19). Activation of caspase-1 was confirmed by the detection of 
autocatalytic processing of caspase-1 into the pi0 and p20 subunits in the 24 hrs samples 
(figure 19). ProIL-l(3 was induced 24 hrs after LPS injection, but the cleaved IL-lp was 
not seen due to its secretion. These results correlate with our previous results with 
Salmonella infection, in which a-enolase and aldolase were degraded 24 hrs 
post-infection (figure 18). The consequence of the degradation of the glycolysis enzymes 
would be to shut down the glycolytic energy source, leading to cell death. In future 
experiments, we will investigate the degradation of the glycolysis enzymes in caspase-1 
knock-out mice upon LPS injection and compare the muscle contractile ability from wild 
type and caspase-1 knock-out mice during septic shock. 
2.3.5 The Glycolytic rate is reduced during Salmonella infection ofTHP-1 
cells 
To test our hypothesis that the consequence of the cleavage of the glycolysis enzymes is 
to shut down this energy source and therefore promote cell death, we compared the 
change in the glycolytic rate of THP-1 cells with and without Salmonella infection. In 
this experiment, we pre-treated THP-1 cells with PMA and infected with salmonella for 4 
hrs. The glycolytic rate of THP-1 cells was assessed by measuring lactate production in 
the presence or absence of the caspase-1 inhibitor YVAD-FMK. As shown in figure 20, 
lactate production decreased by 2 fold after THP-1 cells were infected with Salmonella, 
and caspase-1 inhibitor YVAD-FMK partially reversed this effect. Our results have 
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demonstrated that glycolysis is impaired in THP-1 cells infected with Salmonella, and 
that caspase-1 is involved in this process. 
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CONCLUSIONS AND FUTURE DIRECTIONS: 
We have applied a proteomic approach, the diagnonal gel method, to screen for caspase 
substrates. This method is based on in-gel digestion of substrates by caspases and allows 
identification of caspase substrates from whole cell extracts. In our experiments, we have 
identified 85 and 58 potential substrates for caspases-1 and - 3 , respectively. We have 
validated 8 selected caspase-1 substrates using in vitro cleavage assays. Among the 58 
caspase-3 substrates that we obtained, 19 substrates have been reported in the literature as 
bona fide caspase-3 substrates. Our results have also demonstrated that caspases-1 and -3 
share 25 common substrates, which account for approximately 26% of total caspase-1 
substrates and 38% of total caspase-3 substrates identified by this method. Those 
caspase-1 and -3 substrates are implicated in basic cellular functioning and survival 
(maintenance of the cytoskeleton, translation, glycolysis, bioenergetics, signaling and 
trafficking). 
Another proteomic method, the two-dimensional gel electrophoresis (2D), has been 
applied to search for caspase substrates. In this method, proteins derived from healthy or 
apoptotic cells were separated using 2D gels and the migration patterns of proteins from a 
healthy versus apoptotic cell were compared (Gerner et al., 2000). Although this method 
is also efficient, as few hundred altered protein spots were detected on the 2D gels 
(Gerner et al., 2000), it has the limitation that many substrates of other proteases were 
also detected. However, if we combine the results from the diagonal gel and 2D gel 
approaches, the overlapping substrates from these two methods would represent potential 
true in vivo caspase substrates. In addition, one advantage of our in vitro screening is that 
it could uncover substrates that are undergone degradation soon after their cleavage by 
caspases in vivo. Since those substrates are quickly degraded upon apoptotic stimulation, 
it is impossible to catch them with in vivo screening methods. 
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Our data have indicated that the glycolysis pathway is targeted by caspase-1. Five 
glycolysis enzymes, a-enolase, aldolase, TIM, GAPDH and pyruvate kinase, are cleaved 
by caspase-1. The processing of the above glycolysis enzymes by caspase-1 has been 
confirmed by incubating nanogram amounts of purified recombinant human caspase-1 
with S-methionine-labelled in vitro transcribed and translated substrates. Additionally, 
we have identified the caspase-1 cleavage site in GAPDH as aspartate 189. GAPDH 
with a point mutation of Aspl89->Ala (D189-A) is resistant to cleavage by caspase-1 in 
vitro. In vivo cleavage as well as the consequence of this cleavage remains to be 
investigated. 
We have examined the in vivo cleavage of the glycolysis enzymes in three caspase-1 
activation systems: 1) Stimulation of THP-1 cells with LPS plus ATP or nigericin. This 
condition has been shown to activate caspase-1 within the NALP-3 inflammasome and 
results in the processing and secretion of the caspase-1 substrate IL-ip. In this system, we 
didn't detect any change in the glycolysis enzyme levels or processing. 2) Salmonella 
typhimurium infection of THP-1 cells. This condition has been reported to activate 
caspase-1 within an IPAF inflammasome. In both conditions we failed to observe 
caspase-1 activation and processing by western blot, but we detected high FLICAcasp-1 
staining in response to 24 hour-Salmonella infection, at which point the cells were in an 
advanced phase of cell death and glycolysis enzymes that we examined were degraded. 3) 
Septic shock mice model with LPS induced endotoximia. In this condition, 
auto-processing of caspase-1 was detected and the protein level of the glycolysis enzymes, 
including a-enolase, aldolse, GAPDH and TIM were greatly decreased after 24 hr LPS 
injection although cleavage products of these substrates were not observed. This result 
correlates with that we obtained in Salmonella infection. In combination with our results 
of the cleavage of the glycolysis enzymes by caspase-1 in vitro, we can speculate that 
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those glycolysis enzymes could be degraded after cleavage by caspase-1 in the above two 
conditions. Indeed, caspase substrates are reported to be degraded after cleavage 
(Demontis et al., 2006; Ditzel et al, 2003; Du et al., 2005). Caspases initiate degradation 
of their substrates and target them to be recognized by the ubiquitin/proteosome system. 
Accumulating evidences link the ubiquitin/proteosome pathway to caspase function and 
many researchers have implied a function of caspase-3 in the degradation of proteins 
under pathogenic conditions (Mitch, 2007; Ottenheijm et al., 2006). The involvement of 
caspase-1 in the degradation events has not been previously reported. 
In vivo cleavage of certain substrates by caspases is cell type specific and 
stimulus-specific. For example, GATA-1 is cleaved by caspases in erythroid cells 
undergoing apoptosis in response to erythropeitin (EPO) deprivation or death receptor 
stimulation ((De Maria et al., 1999), but remains uncleaved in erythroid cells undergoing 
terminal differentiation (Zermati et al., 2001); actin can be cleaved by caspases in U397 
leukemia cells, neurons and thymocytes, but not in other cell types undergoing apoptosis 
(Earnshaw et al., 1999). So, this raises the difficulty of capturing the in vivo cleavage 
event of a known in vitro caspase substrate. 
In addition to the above-described caspase-1 activation systems, few other caspase-1 
activation systems remain to be tested and in which we could examine the cleavage of the 
glycolysis enzymes. Caspase-1 knockout mice develop normally and appear healthy and 
fertile, but thymocytes from caspase-1 deficient mice are more resistant to apoptosis 
induced by anti-CD95 antibody (Kuida et al , 1995; Li et al., 1995). This suggests a 
non-redundant function of caspase-1 in this cell type. It would be worthwhile to explore 
the cleavage of the glycolysis enzymes in thymocytes in response to various apoptotic 
stimuli. 
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Although the role of caspase-1 in development is minor, its role in neuronal pathological 
cell death appears to be significant and non-redundant. Dorsal root ganglion neurons in 
caspase-1 deficient mice are partially resistant to apoptosis induced by nerve growth 
factor deprivation (Friedlander et al., 1997b). Excessive apoptosis plays an important role 
in neurodegenerative diseases as well as following cerebral ischemia and head trauma 
(Friedlander et al., 1997a; Friedlander et al., 1997b; Hara et al., 1997). There is ample 
evidence that suggests that caspase-1 plays a unique role in neuronal apoptosis 
(Friedlander et al., 1997b). As well, it has been also proposed that caspase-1 acts as an 
apical mediator of apoptosis during hypoxia-induced neuronal cell death (Zhang et al., 
2003a). 
Hypoxia is a condition of low level of oxygen in tissues. A major intracellular adaptation 
to severe hypoxia is the transition from oxidative phosphorylation to glycolysis as the 
principal means of generating ATP. Under this condition, the hypoxia-inducible factor 
(HIF) pathway is switched on. In order to obtain enough ATP, cells increase their rate of 
glycolysis through stabilization of HIF, which induces the expression of the glucose 
transporter GLUT1 as well as that of certain glycolysis enzymes (Semenza et al., 1994). 
All of the five glycoysis enzymes that are targeted by caspase-1 are known to be HIF-1 
transcriptional targets during hypoxia (Graven et al., 1999; Semenza et al., 1996). The 
role of glycolysis enzymes becomes essential for cell survival in this condition. It is 
therefore important to investigate the function of caspase-1 on these glycolysis enzymes 
in this context. 
Tumor cells display a high rate of glucose uptake and glycolysis even under normal 
oxygen pressure (Warburg, 1930). Accelerated glycolysis ensures ATP levels compatible 
with demands of fast proliferating tumor cells in hypoxic environment. This metabolic 
strategy is commonly observed across tumors (Gatenby and Gillies, 2004). The increased 
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glucose uptake could play a role in protection from apoptosis by rendering tumor cells 
independent of growth factor (Vander Heiden et al., 2001).Inhibition of glucose 
metabolism enhances death receptor mediated apoptosis in tumor cells (Munoz-Pinedo et 
al., 2003). One strategy for tumor cell propagation is through repression of caspases 
(Kurokawa et al., 1999; Teitz et al , 2001). Since we have shown that caspase-1 cleaves 
glycolysis enzymes in vitro, we would ask a question: Do tumor cells block caspase-1 
activation to maintain their glycolytic advantage? To address this hypothesis, we can try 
to induce activation of caspase-1 in tumor cells and examine the cleavage of glycolysis 
enzymes and the relevance of these cleavage events to apoptosis. Previous researchers 
have shown that caspase-1 dependent apoptosis is induced by doxorubicin treatment of 
MCF-7 cells (a breast carcinoma cell line) (Thalappilly et al , 2006). We can use this 
system to test our hypothesis. 
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Figure 4 
1s t dimension gel 2"d dimension gel T a r g e t P r o t e l n s d r oP 
under diagonal line 
Figure 4 Schematic of Diagonal Gel Approach 
Whole cell lysates are separated in 1st dimension SDS-PAGE, gel lanes are excised and 
dehydrated, and then re-hydrated in presence of protease of interest, allowing in-gel 
cleaving of substrates by protease. The processed gel lanes are further resolved by 2nd 
dimension SDS-PAGE. The majority of proteins migrate along diagonal line, whereas 
fragments of substrates cleaved by protease drop under the diagonal line. The dropped 
proteins are identified by MALDI-TOF. 
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Figure 5 Diagonal Gel with Caspase-3 
Whole cell extracts from PBMC were loaded on gel and ran in 1st dimension 
SDS-PAGE. The gel lane was incubated with or without caspase-3 for overnight, 
then ran in 2nd dimension SDS-PAGE. The gels were stained with Sypro Ruby 
and viewed under UV light. (A) without caspase (B) with caspase-3 
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Figure 6 Caspase-1 Substrate IL-1 P Revealed by Western Blot in Diagonal Gel 
THP-1 cells were pretreated with LPS for overnight, 400 [ig proteins from whole cell 
lysates were resolved in 4-12% SDS-PAGE, the lane was hydrated and then incubated 
with human recombinant Caspase-1 (25 [xg) overnight, and again resolved with 4-12% 
SDS-PAGE gel, western blot using IL-1 0 antibody. The dash line represents diagonal. 
The dot drew on diagonal line represents the proform of IL-1 0 (34 KDa). 
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Figure 7 Map of Caspase-3 Digested Diagonal Gel 
Whole cell extracts from PBMC were subjected to SDS PAGE gel and then digested 
with recombinant caspase-3. 2nd dimension gel was stained with silver. The dots 
marked were analyzed by MALDI-TOF. 
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Figure 8 Pie Chart of Caspase-l, -3 Substrates 
(A) Caspase-l substrates (B) Caspase-3 substrates 
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Figure 9 Venn Diagram Comparing Caspase-1 and Caspase-3 Substrates 
(A) Overlapping of caspase-1, caspase-3 substrate in total proteins 
identified by diagonal gel approach 
(B) Overlapping of caspase-1, caspase-3 substrates in cytoskeletal proteins 
identified by diagonal gel approach 
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Figure 10 Caspase-1 Targeted Substrates in Glycolytic Pathway 
Glycolytic pathway converts glucose to pyruvate via glycolysis enzymes. Under 
anaerobic condition, pyruvate is converted to lactate to re-generate NAD+- In this 
pathway, 6 out of total 11 glycolytic enzymes are among our list of casapase-1 
substrates, which are marked with red square. 
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Figure 11 Western Blot of in vitro Cleavage of Glycolysis Enzymes by caspase-1 
Whole cell extracts from THP-1 were incubated with or without recombinant caspase-1 
for 3 hours at 37°C and resolved in 4 - 12% SDS-PAGE, western blot uses antibodies 
against mature IL-113 , aldolase, a - enolase, TIM and GAPDH. Open arrows indicate 
full-length proteins, and closed arrows indicate the cleavage fragments. 
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Figure 12 Western blot of Comparing Cleavage of Glycolysis Enzymes by 
Caspase-1 and -3 
Whole cell extracts from THP-1 cells were incubated with or without caspase-1/ -3 of 
indicated amount for 3 hours at 37 °C, and resolved in 10% SDS-PAGE, cleavgage of 
a - Enolase and aldolase was assessed by western blot. Open arrows indicate full-length 
proteins, and closed arrows indicate the cleavage fragments. 
(A) anti- a -Enolase 
(B) anti- aldolase 
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Figure 13 Comparison of Cleavage of ITT Glycolysis Enzymes by Caspase-1 and 
-3 
in vitro transribed and translated 35S labeled PRAP, GAPDH, TIM, a - Enolase, 
aldolase and pyruvate kinase were incubated with or without recombinant caspase-1 
(170ng) or caspase-3 (290ng) for 4 hours at 37 °C, resolved in 4 - 12% SDS PAGE 
(TIM was resolved in 12% SDS PAGE ) and viewed by autoradiography. Opened arrows 
indicate full-length proteins, closed arrows indicate cleaved fragments. 
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Figure 14 Calibrating cleavage of ITT Glycolysis Enzymes by Caspase-1 
in vitro transribed and translated 35S labeled a - Enolase, aldolase, GAPDH, TIM and pyruvate 
kinase were incubated with or without recombinant caspase-1 of indicated amount for 4 hours at 37 
°C , resolved in 4 - 12% SDS PAGE and viewed by autoradiography. Opened arrows indicate 
full-length proteins, closed arrows indicate cleaved fragments. 
(A) a - Enolase ITT 
(B) Aldolase ITT 
(C) GAPDH ITT 
(D) ProIL-lP ITT 
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Figure 15 Identification of Caspase-1 Cleavage Site of in GAPDH 
(A) Analysis of potential cleavage sites for GAPDH 
(B) Alignment of region containing caspase-1 cleavage site in GAPDH from different 
species 
© Blockage of cleavage of GAPDH by caspase-1 in GAPDH D189A mutant 
In vitro transcribed and translated 35s labeled GAPDH and GAPDH D189A were 
incubated with or without 170 ng recombinant caspase-1 for 4 hours at 37 °C , 
resolved in 4 - 12% SDS PAGE and viewed by autoradiography. Opened arrows 
indicate full-length proteins, closed arrows indicate cleaved fragments. 
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Figure 16 Identification of Caspase-1 Cleavage Site in a - Enolase 
(A)Analyzing cleavage site for a - Enolase 
(B)Failure to block cleavage by caspase-1 in 4 potential cleavage site mutants of 
a-Enolase 
In vitro transcribed and translated 35s labeled a - Enolase and its mutants were incubated 
with or without 170 ng recombinant caspase-1 for 4 hours at 37 °C , resolved in 4 - 12% 
SDS PAGE and viewed by autoradiography. Opened arrows indicate full-length proteins, 
closed arrows indicate cleaved fragments. 
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Figure 17 Western blot of Glycolysis Enzymese in ATP/Nigericin treated 
THP-1 Cells 
THP-1 cells were pre-treated with PMA (20ng/ml) overnight and then treated with LPS (lug/ml) for 3 
hrs and further treated with ATP or nigericin to activate caspase-1. Cells were lysed in SDS loading 
buffer and resolved in 4-12 % SDS PAGE. Western blot was performed using antibodies against 
caspase-1, a - enolase and aldolase. 
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Figure 18 
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Figure 18 Depletion of Glycolysis Enzymes in Salmonella infected THP-1 cells 
THP-1 cells were pre-treated with PMA and primed with LPS and then infected with Salmonella. Activation of caspase-1 was 
monitored by FACS analysis with FLICA08*"1. Cells were lysed in SDS-PAGE buffer and lysates resolved on a 4-12% SDS PAGE. 
Western blot was performed using antibodies against caspase-1, mature IL- 16, oc-enolase, and aldolase. 
(A) FACS with FLICAcasp-1 
(B) Western Blot with antibodies against caspase-1, mature IL-16, a-enolase and aldolase. 
) ) 
i   l i   l l i   i  l onella infecfed THP-1 cells 
   l onel a. Activation of caspase-1 was 
 I casp-l  r   
  ~, a-enolas , 
   
 tc s - 1~,
65 
Figure 19 
** -^ 
Casp-1 
LPS 
00 -
75 -
50 " 
37 -
25 -
20 -
15 " 
• 
. 
IL-1B 
100_ 
75 Z 
50 -
37 " 
25 -
20 -
15 -
^ 
«? 
-? 
«r 
** 
*«» 
a - Enolase 
'-> -
50-
37 " 
25 -
20" 
15 -
10" 
• -• ^mm* 
! 
a - actin 
GAPDH TIM 
66 
~. i   
~ ~ ~ ~ ~ ~ 
LPS ~ ~ ~ ~ ~ ~ ~ ~ ~ 
75 
75 _ 75 
50 50 -
50 _ 
1j$:. ,. • .-. 37 - 37 - ,,",' .. ',)" 37 i~" 
25 - 25 -
- '. .-25 20 - .,... 
-
20 -20 15 : 15 15 - 10 10 10-
-l I -ID 
~ ~
LPS f'V ~ 
75 _  
-75 _ 
50 
... _"',,1'  37 ... -
 -
 -
15  
10-  -
Aldolase 
~ ~ ~ ~ 
 ~ ~ ;: ~ :: ~ 75 _ 
100 _ " ., 
 0 -
 -  -
 +  
0 - .. . ~ - 
  
 - -
 
 
Figure 19 Depletion of glycolysis Enzymes in Mice Muscle with Septic shock 
Mice were injected intraperitoneally with 20mg/kg LPS to induce septic shock. The mice 
were killed 12 or 24 hrs post-injection. Diaphragm muscle was excised, and proteins 
were extracted and subjected in 4-12 SDS PAGE, western blot were performed using 
antibodies against caspase-1, IL-1B, a-enolase, aldolase, GAPDH and actin. 
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Figure 20 Change of Glycolysis Rate in THP-1 Cells After Salmonella Infection 
THP-1 cells were pretreated with PMA( 20 ng/ml) for 18 hrs, and infected with 
Salmonella (moi 1:10) for 4 hrs in the presence or absence of YVAD-FMK. Rate of 
glycolysis was assessed by Lactate production 
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Table 1 Caspase-1 and -3 substrates obtained by diagonal gel approach 
Protein 
Cytoskeletal and membrane proteins 
adenylyl cyclase-associated protein 
actin-related protein 3 
cellular myosin heavy chain 
coronin-like protein 
cytokeratin 9 
F-actin capping protein a-1 subunit 
filamin 1 
gelsolin isoform a 
gelsolin isoform b 
keratin 1 
stomatin peptide 
tropomyosin isoform 
vimentin 
accession 
number 
gi|5453595 
gi|5031573 
gi|553596 
gi| 1002923 
gi|435476 
gi|5453597 
gi|4503745 
gi|4504165 
gi|38044288 
gi|7331218 
gi|181184 
gi|9508585 
gi|37852 
Function 
membrane protein 
membrane protein 
cytoskeletal protein 
cytoskeletal protein 
assembly/signaling 
cytoskeletal protein 
cytoskeletal protein 
cytoskeletal protein 
cytoskeletal protein 
cytoskeletal protein 
cytoskeletal protein 
membrane protein 
cytoskeletal protein 
cytoskeletal protein 
Casp-1 
X 
X 
X 
X 
X 
X 
Casp-3 
X 
X 
X 
X 
X 
X 
X 
X 
X 
Known 
substrate 
X 
X 
X 
X 
X 
X 
X 
--
) ~) / 
l a  -3 substr t  obt i  b  dia l gel appr ach 
-l
 
j   
j  
j l ta1   
j  l ta1  
1 1i
j t ske1 ta1  
 j l ta1    
in 1 j ske1 t 1   
1s j l ta1   
j l ta1  
j 1   
j  
j t ske1 ta1
j l ta1  
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Protein 
ot-actin 
a-tubulin 
P-tubulin 
y-actin 
Chaperons and proteins for folding 
Calnexin 
calreticulin precursor 
glutathione transferase 
gp96 precursor 
accession 
number 
gi| 178027 
gi| 15010550 
gi| 1297274 
gi| 178045 
gi| 13097684 
gi|4757900 
gi|87564 
gi| 15010550 
HSP27 gi|662841 
HSP60 gi|77702086 
HSP70 protein 8 
gi|5729877 
Function 
cytoskeletal protein 
cytoskeletal protein 
cytoskeletal protein 
cytoskeletal protein 
Casp-1 
X 
X 
X 
Casp-3 
X 
X 
X 
X 
Known 
substrate 
X 
X 
X 
X 
retains incorrectly folded 
glycoproteins in ER 
chaperon 
protein folding 
heat shock protein, 
chaperone 
heat shock protein, 
chaperone 
heat shock protein, 
chaperone 
heat shock protein, 
chaperone 
X 
X 
X 
X 
X 
X 
X 
X 
) ") / 
Protein accession i  -l  
s st t  
a~act j  
~ u l j  1  
/3~tub n j  
~ n l  
l
j  
l
j
l  
j
j X 
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Protein 
HSP90 
protein disulfide isomerase-related protein 5 
PPIB precursor 
Transcription and nuclear proteins 
A+U-rich element RNA binding factor 
APEX nuclease 
HI histone family, member 2 
HI histone family, member 3 
Hlb histone 
accession Function 
number 
gi|306891 heat shock protein, 
chaperone 
G i| 1710248 protein folding 
gi| 118090 Peptidyl-prolyl cis-trans 
isomerase B precursor, 
protein folding 
gi|2547076 transcription 
gi| 17939646 transcription 
gi|4885375 structural protein of 
chromatin 
gij4885377 structural protein of 
chromatin 
gi|356168 structural protein of 
chromatin 
) ") 
r t i    Casp-l Casp-3 Known 
r substrate 
l  X X X 
t  l  r t i  foldi  X 
ll18  t i X 
l X 
l t X 
l l  X 
l 148  X 
l t t l t i   X 
71 
Protein 
HMG-1 
accession 
number 
gi|968888 
hnRNP 2H9B 
hnRNPAl 
gi|7739437 
gi| 133254 
hnRNP A2/B1 
hnRNP C1/C2 
hnRNP D 
hnRNP E2 
hnRNP G 
hnRNP H1/H2 
laminin-binding protein 
pl05MCM 
MCM5 
gi|4504447 
gi|62088634 
gi|870743 
gi|460773 
gi|542850 
gi|6065880 
gi|34234 
gi| 1197636 
gi| 1232079 
RNH gi| 12653783 
Function 
structural protein of 
chromatin 
transcription 
Heterogeneous nuclear 
ribonucleoprotein 
Transcription 
transcription 
Transcription 
Transcription 
Transcription 
Transcription 
nulear protein 
replication 
replication 
Casp-1 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
Casp 
X 
X 
X 
X 
X 
X 
Known 
substrate 
X 
Ribonuclease/ angiogenin X 
inhibitor 
72 
) ') / 
t i  accession ti  -l -3  
number t t  
I j f  
j  
I j   uc1 r  
1
I gij45   
l/ j  
j    
j    
P j   
I/ j  
l  
O5 l   
l     
l 783  
 
Protein accession 
number 
U2 small nuclear ribonucleoprotein polypeptide A' gi| 18605961 
Translation machinery 
EEFTu 
EEF1A1 
EEF1D 
EFla-like protein 
EF2 
nascent-polypeptide-asso dated complex a 
ribosomal protein LI3 
ribosomal protein LI 8 
ribosomal protein L6 
ribosomal protein L7a 
ribosomal protein P0 
ribosomal protein S10 
gi|704416 
gi(48735185 
gi|38522 
gi| 12006049 
gi|181969 
gi|5031931 
gi| 15431297 
gi|4506607 
gi|21410970 
gi|4506661 
gi| 12654583 
gi|55665989 
^ 
Function 
transcription 
Casp-1 Casp-3 
X 
Known 
substrate 
X 
elongation factor Tu 
elongation factor-1-a 
elongation factor-1-8 
elongation factor 1 a 
elongation factor 2 
translation 
translation 
translation 
translation 
translation 
translation 
translation 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
73 
') 
l i  i  
EEFTu 
EEFIAI 
EEFID 
EFla-like protein 
ci  
 1  
 1  
 
O
I 
accession 
number 
l 8605961 
l
j  
l
l  
l
l  
l  
j
l
l  
j 83 
l
ctio  -l
tr ri ti  
l ti  f t r   
-l
I ô
a 
 
x
 
 
 
 
') 
 
^ 
/ 
Protein 
ribosomal protein S3 
ribosomal protein S7 
ribosomal protein S9 
accession 
number 
gi|7765076 
gi|337518 
gi|550023 
Immune proteins 
CAP37 gi|240869 
Coagulation factor XIIIA chain precuror 
HLA-I Cw-2 a 
HLA-I heavy chain 
gi|119720 
gi|231429 
gi| 1196444 
Glycolysis and Energy metabolism 
2-phosphopyruvate-hydratasea-enolase gi|693933 
aldolase A gi|28614 
ATP synthase, ATP synthase, H+ transporting, gi|32189394 
mitochondrial Fl complex, |3 subunit precursor 
cationic antimicrobial 
protein 
blood coaguation 
human leukocyte antigen 
human leukocyte antigen 
X 
X 
X 
X 
glucose metabolism 
glycolysis 
energy production 
X 
X 
X 
X 
X 
1 
Casp-1 
X 
X 
X 
Function 
translation 
translation 
translation 
Casp-3 Known 
substrate 
74 
)
 
 
al protein S9 
I  r t i  
II 
 
 a-enolase 
accession 
number 
l
j
l
l
111
l
ll196  
l
l
 t ,  t ,  tr rti , il  
I ~ subunit precurs r 
t l ti  
1 
l
 
 
 
) 
 
Protein accession 
number 
ATP synthase, H+ transporting, mitochondrial Fl gi|13111901 
complex, a subunit, isoform a precursor 
carbonic anhydrase II 
catalase 
dihydrolipoamide dehydrogenase precursor 
eosinophil preperoxidase 
ferritin light subunit 
Glutathione S-Transferase M2-3 
glyceraldehyde-3-phosphate dehydrogenase 
glyoxalase I 
Horf6 A Chain B 
lactoferrin precursor 
leucine aminopeptidase 
malate dehydrogenase (cytosolic) 
malate dehydrogenase (mitochondial) 
Myeloperoxidase 
Myo-Inositol Monophosphatase Chain B 
gi| 179780 
gi| 179950 
gi| 181575 
gi|31183 
gi|182516 
gi|5822513 
gi|31645 
gi|5729842 
gi|3318842 
gi| 12083188 
gi|4335941 
gi|5174539 
gi| 12804929 
gi|494397 
gi|2914661 
) 
Function Casp-1 Casp-3 Known 
substrate 
X 
energy production 
metabolism 
metabolism 
metabolism 
metabolism 
iron storage 
protein folding 
glycolysis 
glucose metabolism 
Peroxidase Enzyme 
iron metabolism 
metabolism 
metabolism 
metabolism 
metabolism 
metabolism 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
75 
) ) 
ti  -l   
s strate 
I j  X  
Il nn
j   
j   
j   
j  
j  
j  
t  j   
1 j  
j  
ri  j  
j  
j  
 j  
 j is  
  j i  
75 
Protein 
NADH cytochrome b5 reductase 
pyruvate kinase 
rho GDP dissociation inhibitor (GDI) 
similar to catalase 
transaldolase 1 
Triosephosphate isomerase, glycolysis 
accession 
number 
gi|553254 
gi|35505 
gi|36038 
gi|4557014 
gi|5803187 
gi| 136066 
Tyrosine 3/tryptophan 5 -monooxygenase activation gi|80477445 
protein, zeta 
a-enolase gi(4503571 
Channels, transporter and signaling 
Annexin Hi 
adenylate kinase 2 isoform b 
ADP-ribosylation factor 4 
Annexin A2 
caspase-1 
gi| 1421662 
gi|7524346 
gi|4502205 
gi| 16306978 
gi|2914146 
Function 
metabolism 
glycolysis 
signaling 
metabolism 
glucose metabolism 
glycolysis 
metabolism 
Casp-1 
X 
X 
X 
X 
X 
glycolysis X 
Casp-3 Known 
substrate 
X 
X 
X 
membrane protein X 
signaling X 
signaling X 
membrane protein X X 
maturation of IL-ip and X X 
apoptosis 
76 
") 
Protein 
 
!
rase 
r
Ii
in
-l 
accession 
r
l
l
l
l
l
ll360  
l  
l  
l  
l
l
il  
l
) 
ti  s -l 
 
 
 
 
 
 
 
 
 
 l ~  
 
) 
Protein accession 
number 
endoplasmic reticulum protein 29 isoform 1 gi|5803013 
gi|56676393 
precursor 
Rho GDP dissociation inhibitor p 
globin p gi|26892090 
GTP binding protein gi|4092054 
guanine nucleotide-binding regulatory protein gi|183182 
a-inhibitory subunit 
migration-inducing gene 10 protein gi|41350401 
p64 CLCP gi|895845 
PA28 P gi|2136005 
polypyrimidine tract-binding protein 1 a gi|4506243 
PPPIA gi| 190281 
proteasome a type, 8 isoform 1 
protein PP4-X 
gi|68303561 
gi|189617 
Rab5 gi|642532 
) 
Function 
signaling 
Casp-1 
X 
Casp-3 Known 
substrate 
signaling X 
O2 transporter 
signaling 
signaling 
signaling 
chloride channel 
proteasome activator 
signaling 
protein phosphatase 
subunit, signaling 
signaling 
I a 
Annexin A4, membrane 
protein 
ras-related small GTP 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
77 
)
r t i  
r  
precursor 
~
~
accession 
number 
j  
j
j
j
1eotide- i i j
 r t  
~
a 
I  
ij 4û1 
j
j
gij4506243 
j190281 
j
j
j
 tr s rt  
1 
l
x
x
x 
 
 
 
 
 
 
 
 
 
 
 
 
 
s strate 
') 
 
') 
Protein accession 
number 
Ran-specific GTPase-activating protein 
serum albumin 
SET translocation 
gi|542991 
gi|28592 
gi|4506891 
TRAP-1 gi| 1082886 
Others 
hypothetical protein LOC345651 
PREDICTED: similar to POTE2A 
unnamed protein product 
gi|63055057 
gi|51460457 
gi|28590 
) 
Function 
binding protein 
signaling 
steroid carrier 
related to myeloid 
leukemia 
TNF receptor type 1 
associated protein 
X 
X 
X 
Casp-1 Casp-3 Known 
substrate 
X 
X 
X 
X 
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') 
rotei  
-l 
 
  
accession 
number 
l  
12
j  
l  
l
l
l
asp-l 
l t  t  l i  
asp-3 
) 
no n 
 
Table 2 Cloning primers for PCR 
cDNA and clone site 
GAPDH (Xhol) 
GAPDH (EcoRl) 
a -enolase (Hindlll) 
a -enolase (NOTI) 
aldolase (Hindlll) 
aldolase (NOTI) 
a -enolase nested (Hindlll) 
a -enolase nested (NOTI) 
aldolase nested (Hindlll) 
aldolase nested (NOTI) 
TIM (HINDIII) 
TIM (NOTI) 
Pyruvate kinase (NOTI) 
Pyruvate kinase (Xhol) 
Primers 
forward 5'-GCGGCTCGAGATGGGGAAGGTGAAGGTCGG-3* 
reverse 5'-GCGGGAATCCTTACTCCTTGGAGGCCATGTGGG-3' 
forward 5*-GCGGAAGCTTATGTCTATTCTCAAGATCCATGCC-3* 
reverse 5'-GCGGGCGGCCGCTTACTTGGCCAAGGGG-3' 
forward 5*-GGCCAAGCTTATGCCCTACCAATATCCAGC-3' 
reverse 5'-GCGGGCGGCCGCTTAATAGGCGTGGTTAGAGACG-3' 
forward 5'-GCGGAAGCTTCGGACAGTATCTGTGGGTACC-3' 
reverse 5'-GCGGGCGGCCGCCGAGCTGCCTGAGCTGACACG-3' 
forward 5'-GCGGAAGCTTGGGGTGCCTCAACCACACTCCG-3' 
reverse S'-GCGGGCGGCCGCGCCCCGAGGAGGCGGCCTCC-S* 
forward 5'-GGCGAAGCTTATGGCGCCCTCCAGGAAGTTCTTCG-3' 
reverse 5'-GGCGGCGGCCGCTCATTGTTTGGCATTGATGATGTCC-3' 
forward S'-GGCGGCGGCCGCATGTCGAAGCCCCATAGTGAAGCCGGG-S' 
reverse 5*-GGCGCTCGAGTCACGGCACAGGAACAACACGCATGG-3' 
") 
/ 
e
a ·enolase (HindlII) 
a ·enolase (NO Tl) 
I I
 
· i lI
·
i I I
l l
l ( I
1 
1 
1 f r r  
1 reverse 
1 
1 for ard 
1 reverse 
1 reverse 
1 reverse 
1 
le  l i  ri  ers f r  
i
'· GTCGG·3'
'· ·
5'·GCGGAAGCTT T TGCC·3'
'· ·
'·GGCCAAGCTTATGCC ·
5'·
'· ·
5'· ·
5'
5 '· CCTCC·3 ,
5 '·  ,
5'-
5'·GGCGGC C 3
5'·GGCGCTCGAGTCACGGCACAG
) 
79 
Table 3 Primers for potential cleavage sites mutagenesis 
cDNA and mutation site 
Primers 
a -enolase 
a -enolase 
a -enolase 
a -enolase 
a -enolase 
a -enolase 
a -enolase 
a -enolase 
GAPDH 
GAPDH 
GAPDH 
GAPDH 
GAPDH 
GAPDH 
GAPDH 
GAPDH 
D136A 
D136A 
D238A 
D238A 
D266A 
D266A 
D286A 
D286A 
D144A 
D144A 
D166A 
D166A 
D189A 
D189A 
D198A 
D198A 
forward 5'-CCCCCTGTACCGCCACATCGCTGCCTTGGCTGGCAACTCTGAAGTCATCC-3' 
reverse 5'-GGATGACTTCAGAGTTGCCAGCCAAGGCAGCGATGTGGCGGTACAGGGGG-3' 
forward 5'-GGGAAAGCTGGCTACACTGCTAAGGTGGTCATCGG-3' 
reverse 5'-CCGATGACCACCTTAGCAGTGTAGCCAGCTTTCCC3-3* 
forward 5-'CTTCAAGTCTCCCGATGCCCCCAGCAGGTACATC-3' 
reverse 5'-GATGTACCTGCTGGGGGCATCGGGAGACTTGAAG-3' 
forward 5'-CAAGTCCTTCATCAAGGCCTACCCAGTGGTGTC-3' 
reverse 5'-GACACCACTGGGTAGGCCTTGATGAAGGACTTG-3' 
forward 5'-GGGTGTGAACCATGAGAAGTATGCCAACAGCCTCAAGATCATCAGC-3' 
reverse 5'-GCTGATGATCTTGAGGCTGTTGGCATACTTCTCATGGTTCACACCC-3' 
forward 5'-CCCTGGCCAAGGTC ATCC ATGCCAACTTTGGTATCGTGGAAGG-3' 
reverse 5'-CCTTCCACGATACCAAAGTTGGCATGGATGACCTTGGCCAGGG-3' 
forward 5'-CTGCCACCCAGAAGACTGTGGCTGGCCCCTCCGGGAAACTGTG-3' 
reverse 5'-CACAGTTTCCCGGAGGGGCCAGCCACAGTCTTCTGGGTGGCAG-3' 
forward 5'-CCCTCCGGGAAACTGTGGCGTGCTGGCCGCGGGGCTCTCCAGAAC-3' 
reverse 5'-GTTCTGGAGAGCCCCGCGGCCAGCACGCCACAGTTTCCCGGAGGG-3' 
.~ ) 
        
5'-CCCCCTGTACC CC T
5'-GGATGACTTCAGA TT
5'-
5'- CC3-3'
5-'
5'-
5'-
5'-
1 5'-GGGTGTGA CC T
5'-GCTGATG TCTT
 ' 
5'-CCTT
5 '-CTGCC CCC  ,
5'-CACA TTT
5'-CCCTCCGGGA CT T  
5'-GTTCTGGA C  
80 
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APPENDIX I Caspase-1 substrate: GATA-4 
GATA-4 belongs to the GATA family of zinc finger transcription factors. It is expressed 
in developing cardiac cells and responsible for cardiac differentiation during early 
embryonic development (Heikinheimo et al., 1994). In adults, GATA-4 continues to be 
expressed in cardiac myocytes (Pikkarainen et al., 2004). It has been proposed that 
GATA-4 is required for the adaptive response of cardiomyocytes (Suzuki et al., 2004). 
GATA-4 was implicated in the protection of cardiac myocytes from apoptosis induced by 
antitumor treatment (Aries et al., 2004; Kim et al., 2003). The function of GATA-4 in cell 
survival was also supported by the fact that over expression of GATA-4 increased 
differentiation of cardiomyocytes, while inhibition of GATA-4 by an antisense strategy 
prevented cardiomyocyte differentiation and triggered extensive apoptosis (Grepin et al., 
1997; Grepin et al., 1995). The action of GATA-4 in cell survival was suggested to occur 
through the the upregulation of Bcl-XL transcription by GATA-4 (Aries et al., 2004). 
It has been shown that doxorubicin treatment induces apoptosis in cultured 
cardiomyocytes and GATA-4 is rapidly depleted during this process (Aries et al., 2004; 
Kim et al., 2003). To identify the factors that are responsible for the GATA-4 depletion 
during apoptosis, Dr. Mona Nemer' lab collaborated with our lab. Since there exist 
potential caspase-1 and -3 cleavage sites in the GATA-4 protein, we first tested the 
cleavage of GATA-4 by casapses-1, and - 3 . We in vitro transcribed and translated 35S 
labeled rat GATA-4 and digested with recombinant caspase-1 and - 3 . Our results show 
that GATA-4 is cleaved by caspase-1 in vitro, but not by caspase-3 (Appendix I figure 1 
A). Site-directed mutagenesis of potential cleavage sites of GATA-4 revealed that a 
combination of two point mutations D168A and D230A blocked caspase-1 cleavage 
(Appendix I figure 1 B, C). The cleavage sequences are YMAD168iV and WRRD230|G, 
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which fit the criteria of a bulky or hydrophobic amino acid in the P4 position of a 
caspase-1 substrate, and a small non-charged amino acid in the PI ' position. Alignment 
of the GATA-4 sequences from different species showed that the cleavage site 
WRRD230|G is conserved in all the species examined, while the cleavage site 
YMAD168,|,V is conserved only in mammals (Appendix I figure 1 D). Structurally, 
GATA-4 contains an N-terminal and a possible C-terminal transcriptional activation 
domains, as well as two adjacent zinc fingers in the middle (Appendix I figure 2). 
Caspase-1 cleaves GATA-4 at YMAD168jV removing its N-terminal transcriptional 
activation domain and at WRRD230|G breaking one of its two zinc finger domains. 
Therefore, we hypothesize that the cleavage of GATA-4 by caspase-1 causes its 
inactivation. 
Dr. Nemer and her colleagues have observed that GATA-4 was rapidly degraded 3 hours 
after doxorubicin treatment of cultured cardiomyocytes (Aries et al., 2004). Cleavage 
products of GATA-4 were not detected by western blot. So, for future work, we need to 
confirm the in vivo cleavage of GATA-4 by caspase-1. Since it has been reported that 
some caspase substrates are degraded by the Ubiquitin/proteosome pathway (Demontis et 
al., 2006; Ditzel et al., 2003; Du et al., 2005), in a next step, we can test the possibility of 
GATA-4 degradation by this system. To do this, we would first inhibit the proteosome 
using the proteosome inhibitor LLnL, we would then expect the visualization of GATA-4 
cleavage after Doxorubicin treatment. After the in vivo cleavage of GATA-4 by caspase-1 
is confirmed, we will investigate the relevance of the GATA-4 cleavage on cell survival. 
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Appendix figure 1 Caspase-1 substrate GATA-4 
(A) In vitro cleavage of ITT GATA-4 by caspase-1 and -3 
(B) Analysis of GATA-4 cleavage sites 
(C) Blockage of caspase-1 cleaving GATA-4 mutant (D168A D230A) 
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Appendix Figure 2 Functional Structure of GATA-4 
(Adapted from Pikkarainen el., 2004) 
GATA-4 contains an N-terminal and a possible C-terminal transcriptional activation 
domains, as well as two adjacent zinc fingers in the middle. Caspase-1 cleaves GATA-4 
at YMAD168 I V removing its N-terminal transcriptional activation domain and at 
WRRD230 \ G breaking one of its two zinc finger domains. 
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